Smoking and Atherosclerotic Cardiovascular Disease: Part II: Role of Cigarette Smoking in Cardiovascular Disease Development

• Villablanca AC , McDonaldJM, RutledgeJC: Smoking and cardiovascular disease.Clin. Chest Med.21, 159–172 (2000).
   PubMed Web of Science ®Google Scholar
• IARC: Chemistry and analysis of tobacco smoke. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Tobacco Smoking. 83–126 (1986).
   Google Scholar
• Green CR , RodgmanA: The tobacco chemists – research conference: a half century forum for advances in analytical methodology of tobacco and its products.Recent Adv. Tobacco Sci.22, 131–304 (1996).
   Google Scholar
• Hoffmann D , HoffmannI: Chemistry and toxicology (chapter: 3; NIH publication c 98–4302). National Institutes of Health. Cigars: health effects and trends – smoking and tobacco control monograph no. 9. National Institutes of Health, Washington DC, USA, 55–104 (1998).
   Google Scholar
• Pillsbury HC , BrightCC, O‘ConnorKJ, IrishFW: Tar and nicotine in cigarette smoke.J. Assoc. Off. Anal. Chem.52, 458–462 (1969).
   Google Scholar
• Smith CJ , FischerTH: Particulate and vapor phase constituents of cigarette mainstream smoke and risk of myocardial infarction.Atherosclerosis158, 257–267 (2001).
   PubMed Web of Science ®Google Scholar
• Benowitz NL : The role of nicotine in smoking-related cardiovascular disease.Prev. Med.26, 412–417 (1997).
   PubMed Web of Science ®Google Scholar
• Pittilo RM : Cigarette smoking, endothelial injury and cardiovascular disease.J. Exp. Path.81, 219–230 (2000).
   PubMed Web of Science ®Google Scholar
• Armitage AK , DolleryCT, GeorgeCF, HousemanTH, LewisPJ, TurnerDM: Absorption and metabolism of nicotine from cigarettes.BMJ4, 313–316 (1975).
   PubMed Web of Science ®Google Scholar
• Benowitz NL , HanssonA, JacobP III: Cardiovascular effects of nasal and transdermal nicotine and cigarette smoking. Hypertension39, 1107–1112 (2002).
   PubMed Web of Science ®Google Scholar
• Benowitz NL , FitzgeraldGA, WilsonM, ZhangQ: Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking.J. Am. Coll. Cardiol.22, 1159–1167 (1993).
   PubMed Web of Science ®Google Scholar
• Aicher A , HeeschenC, MohauptM, CookeJP, ZeiherAM, DimmelerS: Nicotine strongly activates dendritic cell-mediated adaptive immunity: potential role for progression of atherosclerotic lesions.Circulation107, 604–611 (2003).
   PubMed Web of Science ®Google Scholar
• Neunteufl T , HeherS, KostnerKet al. : Contribution of nicotine to acute endothelial dysfunction in long-term smokers:J. Am. Coll. Cardiol.239, 251–256 (2002).
   Google Scholar
• Villablanca AC : Nicotine stimulates DNA synthesis and proliferation in vascular endothelial cells in vitro.J. Appl. Physiol.84, 2089–2098 (1998).
   PubMed Web of Science ®Google Scholar
• Heeschen C , JangJJ, WeisMet al. : Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis.Nat. Med.7, 833–839 (2001).
   PubMed Web of Science ®Google Scholar
• SRNT Subcommittee on Biochemical Verification: Biochemical verification of tobacco use and cessation. Nicotine Tob. Res.149–159 (2002).
   PubMedGoogle Scholar
• Heller WD , SchererG, SennewaldE, AdlkoferF: Misclassification of smoking in a follow-up population study in southern Germany.J. Clin. Epidemiol.51, 211–218 (1998).
   PubMed Web of Science ®Google Scholar
• Borden JT , ManA, ScottDA, LiuKZ: Tobacco-induced alterations to the Fourier-transform infrared spectrum of serum.J. Mol. Med.81, 788–794 (2003).
   PubMed Web of Science ®Google Scholar
• Chale SN : Carbon monoxide poisoning. In: Handbook of Medical Toxicology. Viccellio P (Ed.). Little, Brown & Company, Boston, MA, USA (1993).
   Google Scholar
• Zuckerbraun BS , ChinBY, WegielBet al. : Carbon monoxide reverses established pulmonary hypertension.J. Exp. Med.203, 2109–2119 (2006).
   PubMed Web of Science ®Google Scholar
• Anderson R , TheronAJ, RichardsGA, MyerMS, van Rensburg AJ: Passive smoking by humans sensitizes circulating neutrophils. Am. Rev. Respir. Dis.144, 570–574 (1991).
   PubMed Web of Science ®Google Scholar
• Glantz SA , ParmleyWW: Even a little secondhand smoke is dangerous.JAMA286, 462–463 (2001).
   PubMed Web of Science ®Google Scholar
• Tornqvist H , MillsNL, GonzalezMet al. : Persistent endothelial dysfunction in humans after diesel exhaust inhalation.Am. J. Respir. Crit. Care Med.176, 395–400 (2007).
   PubMed Web of Science ®Google Scholar
• Siafaka A , AngelopoulosE, KritikosKet al. : Acute effects of smoking on skeletal muscle microcirculation monitored by near-infrared spectroscopy.Chest131, 1479–1485 (2007).
   PubMed Web of Science ®Google Scholar
• Ahn YS : Cell-derived microparticles: ‘miniature envoys with many faces‘.J. Thromb. Haemost.3, 884–887 (2005).
   PubMed Web of Science ®Google Scholar
• Panagiotakos DB , ChrysohoouC, PitsavosCet al. : The association between secondhand smoke and the risk of developing acute coronary syndromes, among non-smokers, under the presence of several cardiovascular risk factors: The CARDIO2000 case–control study.BMC Public Health2, 9 (2002).
   PubMed Web of Science ®Google Scholar
• Burghuber OC , PunzengruberC, SinzingerH, HaberP, SilberbauerK: Platelet sensitivity to prostacyclin in smokers and nonsmokers.Chest90, 34–38 (1986).
   PubMed Web of Science ®Google Scholar
• Howard G , BurkeGL, SzkloMet al. : Active and passive smoking are associated with increased carotid wall thickness. The Atherosclerosis Risk in Communities Study.Arch. Intern. Med.154, 1277–1282 (1994).
   PubMedGoogle Scholar
• Howard G , WagenknechtLE, BurkeGLet al. : Cigarette smoking and progression of atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) study.JAMA279, 119–124 (1998).
   PubMed Web of Science ®Google Scholar
• Wells AJ : Passive smoking as a cause of heart disease.J. Am. Coll. Cardiol.24, 546–554 (1994).
   PubMed Web of Science ®Google Scholar
• Celermajer DS , AdamsMR, ClarksonPet al. : Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults.N. Engl. J. Med.334, 150–154 (1996).
   PubMed Web of Science ®Google Scholar
• Panagiotakos DB , PitsavosC, ChrysohoouCet al. : Effect of exposure to secondhand smoke on markers of inflammation: the ATTICA study.Am. J. Med.116, 145 (2004).
   PubMed Web of Science ®Google Scholar
• Schmid P , KaranikasG, KritzHet al. : Passive smoking and platelet thromboxane.Thromb. Res.81, 451–460 (1996).
   PubMed Web of Science ®Google Scholar
• Leone A , MoriL, BertanelliF, FabianoP, FilippelliM: Indoor passive smoking: its effect on cardiac performance.Int. J. Cardiol.33, 247–251 (1991).
   PubMed Web of Science ®Google Scholar
• Ernst A , ZibrakJD: Carbon monoxide poisoning.N. Engl. J. Med.339, 1603–1608 (1998).
   PubMed Web of Science ®Google Scholar
• Allen DR , BrowseNL, RuttDL, ButlerL, FletcherC: The effect of cigarette smoke, nicotine, and carbon monoxide on the permeability of the arterial wall.J. Vasc. Surg.7, 139–152 (1988).
   PubMed Web of Science ®Google Scholar
• Nemmar A , HoetPH, VanquickenborneBet al. : Passage of inhaled particles into the blood circulation in humans.Circulation105, 411–414 (2002).
   PubMed Web of Science ®Google Scholar
• Pekkanen J , PetersA, HoekGet al. : Particulate air pollution and risk of ST-segment depression during repeated submaximal exercise tests among subjects with coronary heart disease: the Exposure and Risk Assessment for Fine and Ultrafine Particles in Ambient Air (ULTRA) study.Circulation106, 933–938 (2002).
   PubMed Web of Science ®Google Scholar
• Verrier RL , MittlemanMA, StonePH: Air pollution: an insidious and pervasive component of cardiac risk.Circulation106, 890–892 (2002).
   PubMed Web of Science ®Google Scholar
• Kannel WB : Contributions of the Framingham Study to the conquest of coronary artery disease.Am. J. Cardiol.62, 1109–1112 (1988).
   PubMed Web of Science ®Google Scholar
• Kagan A , HarrisBR, WinkelsteinW Jr et al.: Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: demographic, physical, dietary and biochemical characteristics.J. Chronic Dis.27, 345–364 (1974).
   PubMedGoogle Scholar
• Solberg LA , StrongJP: Risk factors and atherosclerotic lesions. A review of autopsy studies.Arteriosclerosis3, 187–198 (1983).
   PubMedGoogle Scholar
• Sytkowski PA , KannelWB, D‘AgostinoRB: Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study.N. Engl. J. Med.322, 1635–1641 (1990).
   PubMed Web of Science ®Google Scholar
• Bradford HA : The environment and disease: association or causation?Proc. R. Soc. Med.58, 295–300 (1965).
   PubMedGoogle Scholar
• Winkelmann BR , MaerzW: An epidemiological perspective: society, environment, risk factors, and genetics. Saunders, PA, USA 15–48 (2003).
   Google Scholar
• Hurt RD , CroghanGA, WolterTDet al. : Does smoking reduction result in reduction of biomarkers associated with harm? A pilot study using a nicotine inhaler.Nicotine Tob. Res.2, 327–336 (2000).
   PubMedGoogle Scholar
• Harbour R , MillerJ: A new system for grading recommendations in evidence based guidelines.BMJ323, 334–336 (2001).
   PubMed Web of Science ®Google Scholar
• Braunwald E , AntmanEM, BeasleyJWet al. : ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction – a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the management of patients with unstable angina).Am. J. Coll. Cardiol.36, 970–1062 (2000).
   PubMed Web of Science ®Google Scholar
• Braunwald E , AntmanEM, BeasleyJWet al. : ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina).Circulation102, 1193–1209 (2000).
   PubMed Web of Science ®Google Scholar
• Bertrand ME , SimoonsML, FoxKAet al. : Management of acute coronary syndromes: acute coronary syndromes without persistent ST-segment elevation; recommendations of the Task Force of the European Society of Cardiology.Eur. Heart J.21, 1406–1432 (2000).
   PubMed Web of Science ®Google Scholar
• Winkelmann BR , von Holt K, Unverdorben M: Smoking and atherosclerotic cardiovascular disease: Part I: Atherosclerotic disease process. Biomarkers Med.3(4), 411–428 (2009).
   PubMed Web of Science ®Google Scholar
• Hansson GK : Inflammation, atherosclerosis, and coronary artery disease.N. Engl. J. Med.352, 1685–1695 (2005).
   PubMed Web of Science ®Google Scholar
• Kannel WB , AndersonK, WilsonPW: White blood cell count and cardiovascular disease. Insights from the Framingham Study.JAMA267, 1253–1256 (1992).
   PubMed Web of Science ®Google Scholar
• Lavi S , PrasadA, YangEHet al. : Smoking is associated with epicardial coronary endothelial dysfunction and elevated white blood cell count in patients with chest pain and early coronary artery disease.Circulation115, 2621–2627 (2007).
   PubMed Web of Science ®Google Scholar
• Yarnell JW , BakerIA, SweetnamPMet al. : Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies.Circulation83, 836–844 (1991).
   PubMed Web of Science ®Google Scholar
• Sopori M : Effects of cigarette smoke on the immune system.Nat. Rev. Immunol.2, 372–377 (2002).
   PubMed Web of Science ®Google Scholar
• Harel-Meir M , ShererY, ShoenfeldY: Tobacco smoking and autoimmune rheumatic diseases.Nat. Clin. Pract. Rheumatol.3, 707–715 (2007).
   PubMedGoogle Scholar
• Erkan D , YaziciY, PetersonMG, SammaritanoL, LockshinMD: A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome.Rheumatology (Oxf.)41, 924–929 (2002).
   PubMed Web of Science ®Google Scholar
• Harrison BJ , SilmanAJ, HiderSL, HerrickAL: Cigarette smoking as a significant risk factor for digital vascular disease in patients with systemic sclerosis.Arthritis Rheum.46, 3312–3316 (2002).
   PubMed Web of Science ®Google Scholar
• Shoenfeld Y , GerliR, DoriaAet al. : Accelerated atherosclerosis in autoimmune rheumatic diseases.Circulation112, 3337–3347 (2005).
   PubMed Web of Science ®Google Scholar
• Gerli R , ShererY, VaudoGet al. : Early atherosclerosis in rheumatoid arthritis: effects of smoking on thickness of the carotid artery intima media.Ann. NY Acad. Sci.1051, 281–290 (2005).
   PubMed Web of Science ®Google Scholar
• Cavusoglu E , ChopraV, GuptaAet al. : Usefulness of the white blood cell count as a predictor of angiographic findings in an unselected population referred for coronary angiography.Am. J. Cardiol.98, 1189–1193 (2006).
   PubMed Web of Science ®Google Scholar
• Lowe GD , MachadoSG, KrolWF, BartonBA, ForbesCD: White blood cell count and haematocrit as predictors of coronary recurrence after myocardial infarction.Thromb. Haemost.54, 700–703 (1985).
   PubMed Web of Science ®Google Scholar
• Margolis KL , MansonJE, GreenlandPet al. : Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women‘s Health Initiative Observational Study.Arch. Intern. Med.165, 500–508 (2005).
   PubMed Web of Science ®Google Scholar
• Folsom AR , WuKK, RosamondWD, SharrettAR, ChamblessLE: Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study.Circulation96, 1102–1108 (1997).
   PubMed Web of Science ®Google Scholar
• Lee CD , FolsomAR, NietoFJ, ChamblessLE, ShaharE, WolfeDA: White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African–American and White men and women: atherosclerosis risk in communities study.Am. J. Epidemiol.154, 758–764 (2001).
   PubMed Web of Science ®Google Scholar
• Prentice RL , SzatrowskiTP, FujikuraT, KatoH, MasonMW, HamiltonHH: Leukocyte counts and coronary heart disease in a Japanese cohort.Am. J. Epidemiol.116, 496–509 (1982).
   PubMed Web of Science ®Google Scholar
• Coller BS : Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene?Arterioscler. Thromb. Vasc. Biol.25, 658–670 (2005).
   PubMed Web of Science ®Google Scholar
• Grimm RH Jr, Neaton JD, Ludwig W: Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. JAMA254, 1932–1937 (1985).
   PubMed Web of Science ®Google Scholar
• Weijenberg MP , FeskensEJ, KromhoutD: White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men.Arterioscler. Thromb. Vasc. Biol.16, 499–503 (1996).
   PubMed Web of Science ®Google Scholar
• Shankar A , MitchellP, RochtchinaE, WangJJ: The association between circulating white blood cell count, triglyceride level and cardiovascular and all-cause mortality: population-based cohort study.Atherosclerosis192(1), 177–183 (2007).
   PubMed Web of Science ®Google Scholar
• Sherwin R , KaelberCT, KezdiP, KjelsbergMO, ThomasHE Jr: The multiple risk factor intervention trial (MRFIT) II. The development of the protocol. Prev. Med.10, 402–425 (1981).
   PubMed Web of Science ®Google Scholar
• Bovill EG , BildDE, HeissGet al. : White blood cell counts in persons aged 65 years or more from the Cardiovascular Health Study. Correlations with baseline clinical and demographic characteristics.Am. J. Epidemiol.143, 1107–1115 (1996).
   PubMed Web of Science ®Google Scholar
• Winkelmann BR , BoehmBO, NauckMet al. : Cigarette smoking is independently associated with markers of endothelial dysfunction and hyperinsulinaemia in nondiabetic individuals with coronary artery disease.Curr. Med. Res. Opin.17, 132–141 (2001).
   PubMed Web of Science ®Google Scholar
• Freedman DS , FlandersWD, BarboriakJJ, MalarcherAM, GatesL: Cigarette smoking and leukocyte subpopulations in men.Ann. Epidemiol.6, 299–306 (1996).
   PubMed Web of Science ®Google Scholar
• Freedman DS , JoesoefM, RarboriakJJ, StalloneDD, ByersTE: Correlates of leukocyte counts in men.Ann. Epidemiol.6, 74–82 (1996).
   PubMed Web of Science ®Google Scholar
• Botti TP , AminH, HiltscherL, WisslerRW: A comparison of the quantitation of macrophage foam cell populations and the extent of apolipoprotein E deposition in developing atherosclerotic lesions in young people: high and low serum thiocyanate groups as an indication of smoking. PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth.Atherosclerosis124, 191–202 (1996).
   PubMed Web of Science ®Google Scholar
• Boutet M , BazinM, TurcotteH, LagaceR: Effects of cigarette smoke on rat thoracic aorta.Artery7, 56–72 (1980).
   PubMedGoogle Scholar
• Bazin M , TurcotteH, LagaceR, BoutetM: [Cardiovascular effects of cigarette smoke in the rat. Aortic endothelial and myocardial capillary permeability in the rat].Rev. Can. Biol.40, 263–276 (1981).
   PubMedGoogle Scholar
• Ford ES , GilesWH: Serum C-reactive protein and fibrinogen concentrations and self-reported angina pectoris and myocardial infarction: findings from National Health and Nutrition Examination Survey III.J. Clin. Epidemiol.53, 95–102 (2000).
   PubMed Web of Science ®Google Scholar
• Bazzano LA , HeJ, MuntnerP, VupputuriS, WheltonPK: Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States.Ann. Intern. Med.138, 891–897 (2003).
   PubMed Web of Science ®Google Scholar
• Rohde LE , HennekensCH, RidkerPM: Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men.Am. J. Cardiol.84, 1018–1022 (1999).
   PubMed Web of Science ®Google Scholar
• Lowe GD , YarnellJW, RumleyA, BaintonD, SweetnamPM: C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study: are inflammation and fibrin turnover linked in pathogenesis?Arterioscler. Thromb. Vasc. Biol.21, 603–610 (2001).
   PubMed Web of Science ®Google Scholar
• Tracy RP , PsatyBM, MacyEet al. : Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects.Arterioscler. Thromb. Vasc. Biol.17, 2167–2176 (1997).
   PubMed Web of Science ®Google Scholar
• Palosuo T , HusmanT, KoistinenJ, AhoK: C-reactive protein in population samples.Acta Med. Scand.220, 175–179 (1986).
   PubMedGoogle Scholar
• Mendall MA , PatelP, BallamL, StrachanD, NorthfieldTC: C reactive protein and its relation to cardiovascular risk factors: a population based cross-sectional study.BMJ312, 1061–1065 (1996).
   PubMed Web of Science ®Google Scholar
• Mendall MA , StrachanDP, ButlandBKet al. : C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men.Eur. Heart J.21, 1584–1590 (2000).
   PubMed Web of Science ®Google Scholar
• Haverkate F , ThompsonSG, PykeSD, GallimoreJR, PepysMB: Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.Lancet349, 462–466 (1997).
   PubMed Web of Science ®Google Scholar
• Lindberg G , RastamL, GullbergB, LundbladA, Nilsson-EhleP, HansonBS: Serum concentrations of total sialic acid and sialoglycoproteins in relation to coronary heart disease risk markers.Atherosclerosis103, 123–129 (1993).
   PubMed Web of Science ®Google Scholar
• Lindberg G , RastamL, GullbergB, EklundGA, TornbergS: Serum sialic acid concentration and smoking: a population based study.BMJ303, 1306–1307 (1991).
   PubMedGoogle Scholar
• Tappia PS , TroughtonKL, Langley-EvansSC, GrimbleRF: Cigarette smoking influences cytokine production and antioxidant defense.Clin. Sci.88(4), 485–489 (1995).
   Web of Science ®Google Scholar
• Takeuchi N , KawamuraT, KanaiAet al. : The effect of cigarette smoking on soluble adhesion molecules in middle-aged patients with Type 2 diabetes mellitus.Diabet. Med.19, 57–64 (2002).
   PubMed Web of Science ®Google Scholar
• Blann AD , SteeleC, McCollumCN: The influence of smoking on soluble adhesion molecules and endothelial cell markers.Thromb. Res.85, 433–438 (1997).
   PubMed Web of Science ®Google Scholar
• Blann AD , SeigneurM, SteinerM, MillerJP, McCollumCN: Circulating ICAM-1 and VCAM-1 in peripheral artery disease and hypercholesterolaemia: relationship to the location of atherosclerotic disease, smoking, and in the prediction of adverse events.Thromb. Haemost.79, 1080–1085 (1998).
   PubMed Web of Science ®Google Scholar
• Bermudez EA , RifaiN, BuringJ, MansonJE, RidkerPM: Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women.Arterioscler. Thromb. Vasc. Biol.22, 1668–1673 (2002).
   PubMed Web of Science ®Google Scholar
• Adams MR , JessupW, CelermajerDS: Cigarette smoking is associated with increased human monocyte adhesion to endothelial cells: reversibility with oral L-arginine but not vitamin C.J. Am. Coll. Cardiol.29, 491–497 (1997).
   PubMed Web of Science ®Google Scholar
• Saadeddin SM , HabbabMA, FernsGA: Markers of inflammation and coronary artery disease.Med. Sci. Monit.8, RA5–RA12 (2002).
   PubMedGoogle Scholar
• Woodward M , RumleyA, Tunstall-PedoeH, LoweGD: Associations of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular disease.Br. J. Haematol.104, 246–257 (1999).
   PubMed Web of Science ®Google Scholar
• Cohen HJ , HarrisT, PieperCF: Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly.Am. J. Med.114, 180–187 (2003).
   PubMed Web of Science ®Google Scholar
• Blankenberg S , LucG, DucimetierePet al. : Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME).Circulation108, 2453–2459 (2003).
   PubMed Web of Science ®Google Scholar
• de Maat MP , KluftC: The association between inflammation markers, coronary artery disease and smoking.Vascul. Pharmacol.39, 137–139 (2002).
   PubMed Web of Science ®Google Scholar
• Mendall MA , PatelP, AsanteMet al. : Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease.Heart78, 273–277 (1997).
   PubMed Web of Science ®Google Scholar
• Ridker PM , RifaiN, StampferMJ, HennekensCH: Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.Circulation101, 1767–1772 (2000).
   PubMed Web of Science ®Google Scholar
• O‘Malley T , LudlamCA, RiemermsaRA, FoxKA: Early increase in levels of soluble inter-cellular adhesion molecule-1 (sICAM-1); potential risk factor for the acute coronary syndromes.Eur. Heart J.22, 1226–1234 (2001).
   PubMed Web of Science ®Google Scholar
• Chan JC , CheungJC, StehouwerCDet al. : The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the metabolic syndrome – an analysis by structural equation modelling.Int. J. Obes. Relat. Metab. Disord.26, 994–1008 (2002).
   PubMed Web of Science ®Google Scholar
• Bermudez EA , RifaiN, BuringJE, MansonJE, RidkerPM: Relation between markers of systemic vascular inflammation and smoking in women.Am. J. Cardiol.89, 1117–1119 (2002).
   PubMed Web of Science ®Google Scholar
• Fernandez-Real JM , VayredaM, RichartCet al. : Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women.J. Clin. Endocrinol. Metab.86, 1154–1159 (2001).
   PubMed Web of Science ®Google Scholar
• Ridker PM , HennekensCH, BuringJE, RifaiN: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.N. Engl. J. Med.342, 836–843 (2000).
   PubMed Web of Science ®Google Scholar
• Ridker PM , RifaiN, StampferMJ, HennekensCH: Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.Circulation101, 1767–1772 (2000).
   PubMed Web of Science ®Google Scholar
• Pradhan AD , MansonJE, RossouwJEet al. : Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women‘s Health Initiative observational study.JAMA288, 980–987 (2002).
   PubMed Web of Science ®Google Scholar
• Vasan RS : Biomarkers of cardiovascular disease: molecular basis and practical considerations.Circulation113, 2335–2362 (2006).
   PubMed Web of Science ®Google Scholar
• Lee TM , SuSF, SuoWYet al. : Distension of urinary bladder induces exaggerated coronary constriction in smokers with early atherosclerosis.Am. J. Physiol. Heart Circ. Physiol.279, H2838–H2845 (2000).
   PubMed Web of Science ®Google Scholar
• Lee P : The associations of five interleukins with smoking and with risk of heart disease. Internal report. London, UK (2004).
   Google Scholar
• Ohta T , YamashitaN, MaruyamaM, SugiyamaE, KobayashiM: Cigarette smoking decreases interleukin-8 secretion by human alveolar macrophages.Respir. Med.92, 922–927 (1998).
   PubMed Web of Science ®Google Scholar
• Keatings VM , CollinsPD, ScottDM, BarnesPJ: Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma.Am. J. Respir. Crit. Care Med.153, 530–534 (1996).
   PubMed Web of Science ®Google Scholar
• Kuschner WG , D‘AlessandroA, WongH, BlancPD: Dose-dependent cigarette smoking-related inflammatory responses in healthy adults.Eur. Respir. J.9, 1989–1994 (1996).
   PubMed Web of Science ®Google Scholar
• Yamamoto C , YonedaT, YoshikawaMet al. : Airway inflammation in COPD assessed by sputum levels of interleukin-8.Chest112, 505–510 (1997).
   PubMed Web of Science ®Google Scholar
• Morrison D , StrieterRM, DonnellySC, BurdickMD, KunkelSL, MacNeeW: Neutrophil chemokines in bronchoalveolar lavage fluid and leukocyte-conditioned medium from nonsmokers and smokers.Eur. Respir. J.12, 1067–1072 (1998).
   PubMed Web of Science ®Google Scholar
• Roth MD , AroraA, BarskySH, KleerupEC, SimmonsM, TashkinDP: Airway inflammation in young marijuana and tobacco smokers.Am. J. Respir. Crit. Care Med.157, 928–937 (1998).
   PubMed Web of Science ®Google Scholar
• Sher ME , BankS, GreenbergRet al. : The influence of cigarette smoking on cytokine levels in patients with inflammatory bowel disease.Inflamm. Bowel Dis.5, 73–78 (1999).
   PubMed Web of Science ®Google Scholar
• Takizawa H , TanakaM, TakamiKet al. : Increased expression of inflammatory mediators in small-airway epithelium f rom tobacco smokers.Am. J. Physiol. Lung Cell Mol. Physiol.278, L906–L913 (2000).
   PubMed Web of Science ®Google Scholar
• Chalmers GW , MacLeodKJ, ThomsonL, LittleSA, McSharryC, ThomsonNC: Smoking and airway inflammation in patients with mild asthma.Chest120, 1917–1922 (2001).
   PubMed Web of Science ®Google Scholar
• Hellgren J , ErikssonC, KarlssonG, HagbergS, OlinAC, TorenK: Nasal symptoms among workers exposed to soft paper dust.Int. Arch. Occup. Environ. Health74, 129–132 (2001).
   PubMed Web of Science ®Google Scholar
• Abe Y , KawakamiM, KurokiMet al. : Transient rise in serum interleukin-8 concentration during acute myocardial infarction.Br. Heart J.70, 132–134 (1993).
   PubMedGoogle Scholar
• Damas JK , GullestadL, UelandTet al. : CXC-chemokines, a new group of cytokines in congestive heart failure – possible role of platelets and monocytes.Cardiovasc. Res.45, 428–436 (2000).
   PubMed Web of Science ®Google Scholar
• Zhou RH , ShiQ, GaoHQ, ShenBJ: Changes in serum interleukin-8 and interleukin-12 levels in patients with ischemic heart disease in a Chinese population.J. Atheroscler. Thromb.8, 30–32 (2001).
   PubMedGoogle Scholar
• Anguera I , Miranda-GuardiolaF, BoschXet al. : Elevation of serum levels of the anti-inflammatory cytokine interleukin-10 and decreased risk of coronary events in patients with unstable angina.Am. Heart J.144, 811–817 (2002).
   PubMed Web of Science ®Google Scholar
• Romuk E , Skrzep-PoloczekB, WojciechowskaCet al. : Selectin-P and interleukin-8 plasma levels in coronary heart disease patients.Eur. J. Clin. Invest.32, 657–661 (2002).
   PubMed Web of Science ®Google Scholar
• Donger C , GeorgesJL, NicaudVet al. : New polymorphisms in the interleukin-10 gene – relationships to myocardial infarction.Eur. J. Clin. Invest.31, 9–14 (2001).
   PubMed Web of Science ®Google Scholar
• Perez T : [Bronchodilatators and exercise in COPD: effects, evaluation and strategy of use].Rev. Pneumol. Clin.58, 2S11–2S17 (2002).
   PubMedGoogle Scholar
• Gonzalez-Quintela A , VidalC, LojoSet al. : Serum cytokines and increased total serum IgE in alcoholics.Ann. Allergy Asthma Immunol.83, 61–67 (1999).
   PubMed Web of Science ®Google Scholar
• Takanashi S , HasegawaY, KanehiraYet al. : Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers.Eur. Respir. J.14, 309–314 (1999).
   PubMed Web of Science ®Google Scholar
• Koss K , SatsangiJ, FanningGC, WelshKI, JewellDP: Cytokine (TNF-α, LT-α and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies.Genes Immun.1, 185–190 (2000).
   PubMed Web of Science ®Google Scholar
• Reuss E , FimmersR, KrugerA, BeckerC, RittnerC, HohlerT: Differential regulation of interleukin-10 production by genetic and environmental factors – a twin study.Genes Immun.3, 407–413 (2002).
   PubMed Web of Science ®Google Scholar
• Mizia-Stec K , Zahorska-MarkiewiczB, GasiorZ: Cigarette smoking and inflammatory indices in coronary artery disease.Int. J. Cardiol.93, 169–174 (2004).
   PubMed Web of Science ®Google Scholar
• Marriott JB , GoldmanJH, KeelingPJ, BaigMK, DalgleishAG, McKennaWJ: Abnormal cytokine profiles in patients with idiopathic dilated cardiomyopathy and their asymptomatic relatives.Heart75, 287–290 (1996).
   PubMed Web of Science ®Google Scholar
• Aukrust P , UelandT, LienEet al. : Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.Am. J. Cardiol.83, 376–382 (1999).
   PubMed Web of Science ®Google Scholar
• Mazzone A , De Servi S, Vezzoli M et al.: Plasma levels of interleukin 2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease. Atherosclerosis145, 369–374 (1999).
   PubMed Web of Science ®Google Scholar
• Mizia-Stec K , Zahorska-MarkiewiczB, MandeckiT, JanowskaJ, Jastrzebska-MajE, SzymanskiL: [The selected pro- and anti-inflammatory cytokines in the patients with coronary heart disease: preliminary communication].Pol. Arch. Med. Wewn.102, 677–684 (1999).
   PubMedGoogle Scholar
• Yamaoka M , YamaguchiS, OkuyamaM, TomoikeH: Anti-inflammatory cytokine profile in human heart failure: behavior of interleukin-10 in association with tumor necrosis factor-α.Jpn Circ. J.63, 951–956 (1999).
   PubMedGoogle Scholar
• Kimur T , KotajimaN, KandaT, KuwabaraA, FukumuraY, KobayashiI: Correlation of circulating interleukin-10 with thyroid hormone in acute myocardial infarction.Res. Commun. Mol. Pathol. Pharmacol.110, 53–58 (2001).
   PubMedGoogle Scholar
• Loppnow H , WerdanK, WernerC: The enhanced plasma levels of soluble tumor necrosis factor receptors (sTNF-R1; sTNF-R2) and interleukin-10 (IL-10) in patients suffering from chronic heart failure are reversed in patients treated with β-adrenoceptor antagonist.Auton. Autacoid. Pharmacol.22, 83–92 (2002).
   PubMedGoogle Scholar
• Waehre T , HalvorsenB, DamasJKet al. : Inflammatory imbalance between IL-10 and TNFα in unstable angina potential plaque stabilizing effects of IL-10.Eur. J. Clin. Invest.32, 803–810 (2002).
   PubMed Web of Science ®Google Scholar
• Stumpf C , LehnerC, YilmazA, DanielWG, GarlichsCD: Decrease of serum levels of the anti-inflammatory cytokine interleukin-10 in patients with advanced chronic heart failure.Clin. Sci. (Lond.)105, 45–50 (2003).
   PubMed Web of Science ®Google Scholar
• Yamashita H , ShimadaK, SekiE, MokunoH, DaidaH: Concentrations of interleukins, interferon, and C-reactive protein in stable and unstable angina pectoris.Am. J. Cardiol.91, 133–136 (2003).
   PubMed Web of Science ®Google Scholar
• Mizia-Stec K , Zahorska-MarkiewiczB, MandeckiTet al. : Hyperlipidaemias and serum cytokines in patients with coronary artery disease.Acta Cardiol.58, 9–15 ( 2003).
   PubMed Web of Science ®Google Scholar
• Koch W , KastratiA, BottigerC, MehilliJ, von Beckerath N, Schomig A: Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis159, 137–144 (2001).
   PubMed Web of Science ®Google Scholar
• Wang KS , FrankDA, RitzJ: Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4.Blood95, 3183–3190 (2000).
   PubMed Web of Science ®Google Scholar
• Trinchieri G : Interleukin-12 and the regulation of innate resistance and adaptive immunity.Nat. Rev. Immunol.3, 133–146 (2003).
   PubMed Web of Science ®Google Scholar
• Lee TS , YenHC, PanCC, ChauLY: The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice.Arterioscler. Thromb. Vasc. Biol.19, 734–742 (1999).
   PubMed Web of Science ®Google Scholar
• Biet F , LochtC, KremerL: Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens.J. Mol. Med.80, 147–162 (2002).
   PubMed Web of Science ®Google Scholar
• Seta Y , KandaT, TanakaTet al. : Interleukin 18 in acute myocardial infarction.Heart84, 668 (2000).
   PubMed Web of Science ®Google Scholar
• Mallat Z , HenryP, FressonnetRet al. : Increased plasma concentrations of interleukin-18 in acute coronary syndromes.Heart88, 467–469 (2002).
   PubMed Web of Science ®Google Scholar
• Naito Y , TsujinoT, FujiokaY, OhyanagiM, OkamuraH, IwasakiT: Increased circulating interleukin-18 in patients with congestive heart failure.Heart88, 296–297 (2002).
   PubMed Web of Science ®Google Scholar
• Yamaoka-Tojo M , TojoT, MasudaTet al. : C-reactive protein-induced production of interleukin-18 in human endothelial cells: a mechanism of orchestrating cytokine cascade in acute coronary syndrome.Heart Vessels18, 183–187 (2003).
   PubMed Web of Science ®Google Scholar
• Van Tiel E , PeetersPH, SmitHAet al. : Quitting smoking may restore hematological characteristics within five years.Ann. Epidemiol.12, 378–388 (2002).
   PubMed Web of Science ®Google Scholar
• Smith MR , KinmonthAL, LubenRNet al. : Smoking status and differential white cell count in men and women in the EPIC-Norfolk population.Atherosclerosis169, 331–337 (2003).
   PubMed Web of Science ®Google Scholar
• Unverdorben M , van der Bijl A, Potgieter L, Liang Q, Roethig HJ: Spiroergometry in adult smokers comparing a conventional cigarette to an electrical heated cigarette smoking system. J. Clin. Pharmacol.45, 1069 (2005).
   Google Scholar
• Corwin EJ , KleinLC: C-reactive protein and depressed mood in a sub-group of smokers during nicotine abstinence.Hum. Psychopharmacol.18, 329–337 (2003).
   PubMed Web of Science ®Google Scholar
• Zevin S , SaundersS, GourlaySG, JacobP, BenowitzNL: Cardiovascular effects of carbon monoxide and cigarette smoking.J. Am. Coll. Cardiol.38, 1633–1638 (2001).
   PubMed Web of Science ®Google Scholar
• Crook MA , ScottDA, StapletonJA, PalmerRM, WilsonRF, SutherlandG: Circulating concentrations of C-reactive protein and total sialic acid in tobacco smokers remain unchanged following one year of validated smoking cessation.Eur. J. Clin. Invest.30, 861–865 (2000).
   PubMed Web of Science ®Google Scholar
• Ohsawa M , OkayamaA, NakamuraMet al. : CRP levels are elevated in smokers but unrelated to the number of cigarettes and are decreased by long-term smoking cessation in male smokers.Prev. Med.41, 651–656 (2005).
   PubMed Web of Science ®Google Scholar
• Lao XQ , JiangCQ, ZhangWSet al. : Smoking, smoking cessation and inflammatory markers in older Chinese men: The Guangzhou Biobank Cohort Study.Atherosclerosis203(1), 304–310 (2009).
   PubMed Web of Science ®Google Scholar
• Lind P , EngstromG, StavenowL, JanzonL, LindgardeF, HedbladB: Risk of myocardial infarction and stroke in smokers is related to plasma levels of inflammation-sensitive proteins.Arterioscler. Thromb. Vasc. Biol.24, 577–582 (2004).
   PubMed Web of Science ®Google Scholar
• Wannamethee SG , LoweGD, ShaperAG, RumleyA, LennonL, WhincupPH: Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease.Eur. Heart J.26, 1765–1773 (2005).
   PubMed Web of Science ®Google Scholar
• Puranik R , CelermajerDS: Smoking and endothelial function.Prog. Cardiovasc. Dis.45, 443–458 (2003).
   PubMed Web of Science ®Google Scholar
• Celermajer DS , SorensenKE, GeorgakopoulosDet al. : Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults.Circulation88, 2149–2155 (1993).
   PubMed Web of Science ®Google Scholar
• Ijzerman RG , SerneEH, van Weissenbruch MM, de Jongh RT, Stehouwer CD: Cigarette smoking is associated with an acute impairment of microvascular function in humans. Clin. Sci. (Lond.)104, 247–252 (2003).
   PubMed Web of Science ®Google Scholar
• Enderle MD , PfohlM, KellermannN, HaeringHU, HoffmeisterHM: Endothelial function, variables of fibrinolysis and coagulation in smokers and healthy controls.Haemostasis30, 149–158 (2000).
   PubMedGoogle Scholar
• Moreno HJ , ChalonS, UraeAet al. : Endothelial dysfunction in human hand veins is rapidly reversible after smoking cessation.Am. J. Physiol.275, H1040–H1045 (1998).
   PubMedGoogle Scholar
• Barua RS , AmbroseJA, Eales-ReynoldsLJ, DeVoeMC, ZervasJG, SahaDC: Dysfunctional endothelial nitric oxide biosynthesis in healthy smokers with impaired endothelium-dependent vasodilatation.Circulation104, 1905–1910 (2001).
   PubMed Web of Science ®Google Scholar
• Butler R , MorrisAD, StruthersAD: Cigarette smoking in men and vascular responsiveness.Br. J. Clin. Pharmacol.52, 145–149 (2001).
   PubMed Web of Science ®Google Scholar
• Chalon S , MorenoHJ, HoffmanBB, BlaschkeTF: Angiotensin-converting enzyme inhibition improves venous endothelial dysfunction in chronic smokers.Clin. Pharmacol. Ther.65, 295–303 (1999).
   PubMed Web of Science ®Google Scholar
• Celermajer DS , SorensenKE, GoochVMet al. : Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis.Lancet340, 1111–1115 (1992).
   PubMed Web of Science ®Google Scholar
• Lekakis J , PapamichaelC, VemmosC, StamatelopoulosK, VoutsasA, StamatelopoulosS: Effects of acute cigarette smoking on endothelium-dependent arterial dilatation in normal subjects.Am. J. Cardiol.81, 1225–1228 (1998).
   PubMed Web of Science ®Google Scholar
• Lekakis J , PapamichaelC, VemmosCet al. : Effect of acute cigarette smoking on endothelium-dependent brachial artery dilatation in healthy individuals.Am. J. Cardiol.79, 529–531 (1997).
   PubMed Web of Science ®Google Scholar
• Raitakari OT , AdamsMR, McCredieRJ, GriffithsKA, CelermajerDS: Arterial endothelial dysfunction related to passive smoking is potentially reversible in healthy young adults.Ann. Intern. Med.130, 578–581 (1999).
   PubMed Web of Science ®Google Scholar
• Bonetti PO , PumperGM, HiganoST, HolmesDR Jr, Kuvin JT, Lerman A: Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J. Am. Coll. Cardiol.44, 2137–2141 (2004).
   PubMed Web of Science ®Google Scholar
• Kuvin JT , PatelAR, SlineyKAet al. : Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude.Am. Heart J.146, 168–174 (2003).
   PubMed Web of Science ®Google Scholar
• Jensen EW , BrydeAH, NielsenSL, ChristensenNJ: Long-term smoking increases transcapillary escape rate of albumin.Scand. J. Clin. Lab. Invest.52, 653–656 (1992).
   PubMed Web of Science ®Google Scholar
• Jensen EW , EspersenK, KnudsenJH, NielsenSL: Increased transcapillary escape rate of albumin in elderly subjects due to long-term smoking habits.Clin. Physiol.15, 159–167 (1995).
   PubMedGoogle Scholar
• Blann A , BignellA, McCollumC: von Willebrand factor, fibrinogen and other plasma proteins as determinants of plasma viscosity.Atherosclerosis139, 317–322 (1998).
   PubMed Web of Science ®Google Scholar
• Mannucci PM : von Willebrand factor: a marker of endothelial damage?Arterioscler. Thromb. Vasc. Biol.18, 1359–1362 (1998).
   PubMed Web of Science ®Google Scholar
• Conway DS , PearceLA, ChinBS, HartRG, LipGY: Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors.Circulation106, 1962–1967 (2002).
   PubMed Web of Science ®Google Scholar
• Zeiher AM , SchachingerV, MinnersJ: Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function.Circulation92, 1094–1100 (1995).
   PubMed Web of Science ®Google Scholar
• Hambrecht R , WolfA, GielenSet al. : Effect of exercise on coronary endothelial function in patients with coronary artery disease.N. Engl. J. Med.342, 454–460 (2000).
   PubMed Web of Science ®Google Scholar
• Stadler RW , IbrahimSF, LeesRS: Measurement of the time course of peripheral vasoactivity: results in cigarette smokers.Atherosclerosis138, 197–205 (1998).
   PubMed Web of Science ®Google Scholar
• Pedrinelli R , Dell‘OmoG, PennoG, MarianiM: Non-diabetic microalbuminuria, endothelial dysfunction and cardiovascular disease.Vasc. Med.6, 257–264 (2001).
   PubMed Web of Science ®Google Scholar
• Jellinek H : The role of transmural fluxes and vascular permeability in atherogenesis. In: Anders G, Olsson MD (Eds.) Atherosclerosis Biology and Clinical Science. Churchill Livingstone, NY, USA (1987).
   Google Scholar
• Jellinek H , DetreZ: Role of the altered transmural permeability in the pathomechanism of arteriosclerosis. History of arteriosclerosis theories – role of the altered transmural permeability in experimental arteriosclerosis models.Pathol. Res. Pract.181, 693–712 (1986).
   PubMed Web of Science ®Google Scholar
• Takacs E , JellinekH: Early morphological changes of vessels in an experimental model system.Int. Angiol.6, 7–19 (1987).
   PubMed Web of Science ®Google Scholar
• Kharitonov SA , RobbinsRA, YatesD, KeatingsV, BarnesPJ: Acute and chronic effects of cigarette smoking on exhaled nitric oxide.Am. J. Respir. Crit. Care Med.152, 609–612 (1995).
   PubMed Web of Science ®Google Scholar
• Jaimes EA , DeMasterEG, TianRX, RaijL: Stable compounds of cigarette smoke induce endothelial superoxide anion production via NADPH oxidase activation.Arterioscler. Thromb. Vasc. Biol.24, 1031–1036 (2004).
   PubMed Web of Science ®Google Scholar
• Kavdia M , PopelAS: Contribution of nNOS- and eNOS-derived NO to microvascular smooth muscle NO exposure.J. Appl. Physiol.97, 293–301 (2004).
   PubMed Web of Science ®Google Scholar
• Demady DR , LoweER, EverettACet al. : Metabolism-based inactivation of neuronal nitric-oxide synthase by components of cigarette and cigarette smoke.Drug Metab. Dispos.31, 932–937 (2003).
   PubMed Web of Science ®Google Scholar
• Kugiyama K , YasueH, OhgushiMet al. : Deficiency in nitric oxide bioactivity in epicardial coronary arteries of cigarette smokers.J. Am. Coll. Cardiol.28, 1161–1167 (1996).
   PubMed Web of Science ®Google Scholar
• Winniford MD , JansenDE, ReynoldsGA, ApprillP, BlackWH, HillisLD: Cigarette smoking-induced coronary vasoconstriction in atherosclerotic coronary artery disease and prevention by calcium antagonists and nitroglycerin.Am. J. Cardiol.59, 203–207 (1987).
   PubMed Web of Science ®Google Scholar
• Barua RS , AmbroseJA, Eales-ReynoldsLJ, DeVoeMC, ZervasJG, SahaDC: Heavy and light cigarette smokers have similar dysfunction of endothelial vasoregulatory activity: an in vivo and in vitro correlation.J. Am. Coll. Cardiol.39, 1758–1763 (2002).
   PubMed Web of Science ®Google Scholar
• Pellaton C , KubliS, FeihlF, WaeberB: Blunted vasodilatory responses in the cutaneous microcirculation of cigarette smokers.Am. Heart J.144, 269–274 (2002).
   PubMed Web of Science ®Google Scholar
• Nene S , GelabertH, MooreW, Quinones-BaldrichW, Santibanez-GalleraniA, IgnarroL: Cigarette smoking increases endothelial-derived vasorelaxation in the rat carotid artery in a dose-dependent manner.J. Surg. Res.71, 101–106 (1997).
   PubMed Web of Science ®Google Scholar
• Node K , KitakazeM, YoshikawaH, KosakaH, HoriM: Reversible reduction in plasma concentration of nitric oxide induced by cigarette smoking in young adults.Am. J. Cardiol.79, 1538–1541 (1997).
   PubMed Web of Science ®Google Scholar
• Tsuchiya M , AsadaA, KasaharaE, SatoEF, ShindoM, InoueM: Smoking a single cigarette rapidly reduces combined concentrations of nitrate and nitrite and concentrations of antioxidants in plasma.Circulation105, 1155–1157 (2002).
   PubMed Web of Science ®Google Scholar
• Yanagisawa M , KuriharaH, KimuraSet al. : A novel potent vasoconstrictor peptide produced by vascular endothelial cells.Nature332, 411–415 (1988).
   PubMed Web of Science ®Google Scholar
• Noori A , KabbaniS: Endothelins and coronary vascular biology.Coron. Artery Dis.14, 491–494 (2003).
   PubMed Web of Science ®Google Scholar
• Fan J , UnokiH, IwasaS, WatanabeT: Role of endothelin-1 in atherosclerosis.Ann. NY Acad. Sci.902, 84–93 (2000).
   PubMed Web of Science ®Google Scholar
• Masaki T : The endothelin family: an overview.J. Cardiovasc. Pharmacol.35, S3–S5 (2000).
   PubMed Web of Science ®Google Scholar
• Lerman A , HolmesDR Jr, Bell MR, Garratt KN, Nishimura RA, Burnett JC Jr: Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation92, 2426–2431 (1995).
   PubMed Web of Science ®Google Scholar
• Lanza GA , BencardinoG, SestitoAet al. : Association of endothelin-1 with transient myocardial ischemia in patients with unstable angina pectoris.Am. J. Cardiol.95, 492–494 (2005).
   PubMed Web of Science ®Google Scholar
• Kanaya AM , Barrett-ConnorE, Wassel Fyr CL: Endothelin-1 and prevalent coronary heart disease in older men and women (the Rancho Bernardo Study). Am. J. Cardiol.99, 486–490 (2007).
   PubMed Web of Science ®Google Scholar
• Haak T , JungmannE, RaabC, UsadelKH: Elevated endothelin-1 levels after cigarette smoking.Metabolism43, 267–269 (1994).
   PubMed Web of Science ®Google Scholar
• Yildiz L , AkcayF, KaynarH, BakanN: Increased plasma endothelin-1 in heavy and light smokers.Clin. Chem.42, 483–484 (1996).
   PubMed Web of Science ®Google Scholar
• Gambaro G , VerlatoF, BudakovicAet al. : Renal impairment in chronic cigarette smokers.J. Am. Soc. Nephrol.9, 562–567 (1998).
   PubMed Web of Science ®Google Scholar
• Borissova AM , TankovaT, KirilovG, DakovskaL, KrivoshievS: The effect of smoking on peripheral insulin sensitivity and plasma endothelin level.Diabetes Metab.30, 147–152 (2004).
   PubMed Web of Science ®Google Scholar
• Hirai Y , AdachiH, FujiuraY, HiratsukaA, EnomotoM, ImaizumiT: Plasma endothelin-1 level is related to renal function and smoking status but not to blood pressure: an epidemiological study.J. Hypertens.22, 713–718 (2004).
   PubMed Web of Science ®Google Scholar
• Kosicka T , Kara-PerzH, PerzS: [Evaluation of plasma endothelin-1 concentration in tobacco smoking patients with essential hypertension].Przegl. Lek.63, 957–959 (2006).
   PubMedGoogle Scholar
• Barbera JA , PeinadoVI, SantosS, RamirezJ, RocaJ, Rodriguez-RoisinR: Reduced expression of endothelial nitric oxide synthase in pulmonary arteries of smokers.Am. J. Respir. Crit. Care Med.164, 709–713 (2001).
   PubMed Web of Science ®Google Scholar
• Robbins RA , MillatmalT, LassiK, RennardS, DaughtonD: Smoking cessation is associated with an increase in exhaled nitric oxide.Chest112, 313–318 (1997).
   PubMed Web of Science ®Google Scholar
• Kondo T , HayashiM, TakeshitaKet al. : Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers.Arterioscler. Thromb. Vasc. Biol.24, 1442 (2004).
   PubMed Web of Science ®Google Scholar
• Marangon K , HerbethB, LecomteEet al. : Diet, antioxidant status, and smoking habits in French men.Am. J. Clin. Nutr.67, 231–239 (1998).
   PubMed Web of Science ®Google Scholar
• Kunsch C , MedfordRM: Oxidative stress as a regulator of gene expression in the vasculature.Circ. Res.85, 753–766 (1999).
   PubMed Web of Science ®Google Scholar
• Dhalla NS , TemsahRM, NetticadanT: Role of oxidative stress in cardiovascular diseases.J. Hypertens.18, 655–673 (2000).
   PubMed Web of Science ®Google Scholar
• Madamanchi NR , VendrovA, RungeMS: Oxidative stress and vascular disease.Arterioscler. Thromb. Vasc. Biol.25, 29–38 (2005).
   PubMed Web of Science ®Google Scholar
• Andreassi MG , BottoN: DNA damage as a new emerging risk factor in atherosclerosis.Trends Cardiovasc. Med.13, 270–275 (2003).
   PubMed Web of Science ®Google Scholar
• Montuschi P , BarnesPJ, RobertsLJ: Isoprostanes: markers and mediators of oxidative stress.FASEB J.18, 1791–1800 (2004).
   PubMed Web of Science ®Google Scholar
• Block G , DietrichM, NorkusEPet al. : Factors associated with oxidative stress in human populations.Am. J. Epidemiol.156, 274–285 (2002).
   PubMed Web of Science ®Google Scholar
• Dotan Y , LichtenbergD, PinchukI: Lipid peroxidation cannot be used as a universal criterion of oxidative stress.Prog. Lipid Res.43, 200–227 (2004).
   PubMed Web of Science ®Google Scholar
• Astley S : Dietary antoxidants – past, present and future?Trends Food Sci. Tech.14, 93–98 (2003).
   Web of Science ®Google Scholar
• Repine JE , BastA, LankhorstI: Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group.Am. J. Respir. Crit. Care Med.156, 341–357 (1997).
   PubMed Web of Science ®Google Scholar
• Raij L , DeMasterEG, JaimesEA: Cigarette smoke-induced endothelium dysfunction: role of superoxide anion.J. Hypertens.19, 891–897 (2001).
   PubMed Web of Science ®Google Scholar
• Mays BW , FreischlagJA, EgintonMT, CambriaRA, SeabrookGR, TowneJB: Ascorbic acid prevents cigarette smoke injury to endothelium-dependent arterial relaxation.J. Surg. Res.84, 35–39 (1999).
   PubMed Web of Science ®Google Scholar
• Lehr HA , WeyrichAS, SaetzlerRKet al. : Vitamin C blocks inflammatory platelet-activation factor mimetics created by cigarette smoking.J. Clin. Invest.99, 2358–2364 (1997).
   PubMed Web of Science ®Google Scholar
• Frei B , ForteTM, AmesBN, CrossCE: Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Protective effects of ascorbic acid.Biochem. J.277(Pt 1), 133–138 (1991).
   PubMed Web of Science ®Google Scholar
• Mol MJ , de Rijke YB, Demacker PN, Stalenhoef AF: Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking: effects of vitamin E treatment. Atherosclerosis129, 169–176 (1997).
   PubMed Web of Science ®Google Scholar
• Pech-Amsellem MA , MyaraI, StorogenkoM, DemuthK, ProustA, MoattiN: Enhanced modifications of low-density lipoproteins (LDL) by endothelial cells from smokers: a possible mechanism of smoking-related atherosclerosis.Cardiovasc. Res.31, 975–983 (1996).
   PubMed Web of Science ®Google Scholar
• Zaratin A g, Gidlund M, Boschcov P, Castilho Lu, Cotta de Faria E: Antibodies against oxidized low-density lipoprotein in normolipidemic smokers. Am. J. Cardiol.90, 651–653 (2002).
   PubMed Web of Science ®Google Scholar
• Yokode M , KitaT, AraiH, KawaiC, NarumiyaS, FujiwaraM: Cholesteryl ester accumulation in macrophages incubated with low density lipoprotein pretreated with cigarette smoke extract.Proc. Natl Acad. Sci. USA85, 2344–2348 (1988).
   PubMed Web of Science ®Google Scholar
• Nagano Y , AraiH, KitaT: High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification.Proc. Natl Acad. Sci. USA88, 6457–6461 (1997).
   Google Scholar
• Yokode M , UeyamaK, AraiNH, UedaY, KitaT: Modification of high- and low-density lipoproteins by cigarette smoke oxidants.Ann. NY Acad. Sci.786, 245–251 (1996).
   PubMed Web of Science ®Google Scholar
• Van de Vijver LPL , SteygerR, Van Poppel G et al.: Autoantibodies against MDA-LDL in subjects with severe and minor atherosclerosis and healthy population controls. Atherosclerosis122, 245–253 (1996).
   PubMed Web of Science ®Google Scholar
• Fickl H , Van Antwerpen VL, Richards GA et al.: Increased levels of autoantibodies to cardiolipin and oxidised low density lipoprotein are inversely associated with plasma vitamin C status in cigarette smokers. Atherosclerosis124, 75–81 (1996).
   PubMed Web of Science ®Google Scholar
• Karvonen J , KaumaH, KervinenKet al. : Apolipoprotein E polymorphism affects carotid artery atherosclerosis in smoking hypertensive men.J. Hypertens.20, 2371–2378 (2002).
   PubMed Web of Science ®Google Scholar
• Nielsen F , MikkelsenBB, NielsenJB, AndersenHR, GrandjeanP: Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors.Clin. Chem.43, 1209–1214 (1997).
   PubMed Web of Science ®Google Scholar
• Gutteridge JM , HalliwellB: The measurement and mechanism of lipid peroxidation in biological systems.Trends Biochem. Sci.15, 129–135 (1990).
   PubMed Web of Science ®Google Scholar
• Gutteridge JM , HalliwellB: Free radicals and antioxidants in the year 2000. A historical look to the future.Ann. NY Acad. Sci.899, 136–147 (2000).
   PubMed Web of Science ®Google Scholar
• Morrow JD , FreiB, LongmireAWet al. : Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage.N. Engl. J. Med.332, 1198–1203 (1995).
   PubMed Web of Science ®Google Scholar
• Reilly M , DelantyN, LawsonJA, FitzgeraldGA: Modulation of oxidant stress in vivo in chronic cigarette smokers.Circulation94, 19–25 (1996).
   PubMed Web of Science ®Google Scholar
• Oguogho A , LupattelliG, PalumboB, SinzingerH: Isoprostanes quickly normalize after quitting cigarette smoking in healthy adults.Vasa29, 103–105 (2000).
   PubMed Web of Science ®Google Scholar
• Do BK , GarewalHS, ClementsNC, Jr, Peng YM, Habib MP. Exhaled ethane and antioxidant vitamin supplements in active smokers. Chest110, 159–164 (1996).
   PubMed Web of Science ®Google Scholar
• Habib MP , TankLJ, LaneLC, GarewalHS: Effect of vitamin E on exhaled ethane in cigarette smokers.Chest115, 684–690 (1999).
   PubMed Web of Science ®Google Scholar
• Guthikonda S , SinkeyC, BarenzT, HaynesWG: Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers.Circulation107, 416–421 (2003).
   PubMed Web of Science ®Google Scholar
• Wang XL , RainwaterDL, VandeBergJF, MitchellBD, MahaneyMC: Genetic contributions to plasma total antioxidant activity.Arterioscler. Thromb. Vasc. Biol.21, 1190–1195 (2001).
   PubMed Web of Science ®Google Scholar
• Hughes K , ChooM, KuperanP, OngCN, AwTC: Cardiovascular risk factors in relation to cigarette smoking: a population-based survey among Asians in Singapore.Atherosclerosis137, 253–258 (1998).
   PubMed Web of Science ®Google Scholar
• Price JF , MowbrayPI, LeeAJ, RumleyA, LoweGD, FowkesFG: Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study.Eur. Heart J.20, 344–353 (1999).
   PubMed Web of Science ®Google Scholar
• Christan C , DietrichT, HagewaldS, KageA, BernimoulinJP: White blood cell count in generalized aggressive periodontitis after non-surgical therapy.J. Clin. Periodontol.29, 201–206 (2002).
   PubMed Web of Science ®Google Scholar
• Mezzetti A , LapennaD, PierdomenicoSDet al. : Vitamins E, C and lipid peroxidation in plasma and arterial tissue of smokers and non-smokers.Atherosclerosis112, 91–99 (1995).
   PubMed Web of Science ®Google Scholar
• Duthie GG , ArthurJR, BeattieJAet al. : Cigarette smoking, antioxidants, lipid peroxidation, and coronary heart disease.Ann. NY Acad. Sci.686, 120–129 (1993).
   PubMed Web of Science ®Google Scholar
• Lykkesfeldt J , ChristenS, WallockLM, ChangHH, JacobRA, AmesBN: Ascorbate is depleted by smoking and repleted by moderate supplementation: a study in male smokers and nonsmokers with matched dietary antioxidant intakes.Am. J. Clin. Nutr.71, 530–536 (2000).
   PubMed Web of Science ®Google Scholar
• Kharb S , SinghGP: Effect of smoking on lipid profile, lipid peroxidation and antioxidant status in normal subjects and in patients during and after acute myocardial infarction.Clin. Chim. Acta302, 213–219 (2000).
   PubMed Web of Science ®Google Scholar
• Dietrich M , BlockG, HudesMet al. : Antioxidant supplementation decreases lipid peroxidation biomarker F2-isoprostanes in plasma of smokers.Cancer Epidemiol. Biomarkers Prev.11, 7–13 (2002).
   PubMed Web of Science ®Google Scholar
• Alberg AJ , ChenJC, ZhaoH, HoffmanSC, ComstockGW, HelzlsouerKJ: Household exposure to passive cigarette smoking and serum micronutrient concentrations.Am. J. Clin. Nutr.72, 1576–1582 (2000).
   PubMed Web of Science ®Google Scholar
• Schwertner HA : Association of smoking and low serum bilirubin antioxidant concentrations.Atherosclerosis136, 383–387 (1998).
   PubMed Web of Science ®Google Scholar
• Van Hoydonck PG , TemmeEH, SchoutenEG: Serum bilirubin concentration in a Belgian population: the association with smoking status and type of cigarettes.Int. J. Epidemiol.30, 1465–1472 (2001).
   PubMed Web of Science ®Google Scholar
• Haramaki N , IkedaH, TakajoYet al. : Long-term smoking causes nitroglycerin resistance in platelets by depletion of intraplatelet glutathione.Arterioscler. Thromb. Vasc. Biol.21, 1852–1856 (2001).
   PubMed Web of Science ®Google Scholar
• Dallongeville J , MarecauxN, FruchartJC, AmouyelP: Cigarette smoking is associated with unhealthy patterns of nutrient intake: a meta-analysis.J. Nutr.128, 1450–1457 (1998).
   PubMed Web of Science ®Google Scholar
• Halliwell B : Vitamin C: poison, prophylactic or panacea?Trends Biochem. Sci.24, 255–259 (1999).
   PubMed Web of Science ®Google Scholar
• Weinberg RB , VanderWerkenBS, AndersonRA, StegnerJE, ThomasMJ: Pro-oxidant effect of vitamin E in cigarette smokers consuming a high polyunsaturated fat diet.Arterioscler. Thromb. Vasc. Biol.21, 1029–1033 (2001).
   PubMed Web of Science ®Google Scholar
• Stocker R : The ambivalence of vitamin E in atherogenesis.Trends Biochem. Sci.24, 219–223 (1999).
   PubMed Web of Science ®Google Scholar
• Morita H , IkedaH, HaramakiN, EguchiH, ImaizumiT: Only two-week smoking cessation improves platelet aggregability and intraplatelet redox imbalance of long-term smokers.J. Am. Coll. Cardiol.45, 589 (2005).
   PubMed Web of Science ®Google Scholar
• Burke A , FitzgeraldGA: Oxidative stress and smoking-induced vascular injury.Prog. Cardiovasc. Dis.46, 79–90 (2003).
   PubMed Web of Science ®Google Scholar
• Heitzer T , YlaHS, WildE, LuomaJ, DrexlerH: Effect of vitamin E on endothelial vasodilator function in patients with hypercholesterolemia, chronic smoking or both.J. Am. Coll. Cardiol.33, 499–505 (1999).
   PubMed Web of Science ®Google Scholar
• Heitzer T , BrockhoffC, MayerBet al. : Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers : evidence for a d ysfunctional nitric oxide synthase.Circ. Res.86, E36–E41 (2000).
   PubMed Web of Science ®Google Scholar
• Fennessy FM , MoneleyDS, WangJH, KellyCJ, Bouchier-HayesDJ: Taurine and vitamin C modify monocyte and endothelial dysfunction in young smokers.Circulation107, 410–415 (2003).
   PubMed Web of Science ®Google Scholar
• Brown AA , HuFB: Dietary modulation of endothelial function: implications for cardiovascular disease.Am. J. Clin. Nutr.73, 673–686 (2001).
   PubMed Web of Science ®Google Scholar
• Raitakari OT , AdamsMR, McCredieRJ, GriffithsKA, StockerR, CelermajerDS: Oral vitamin C and endothelial function in smokers: short-term improvement, but no sustained beneficial effect.J. Am. Coll. Cardiol.35, 1616–1621 (2000).
   PubMed Web of Science ®Google Scholar
• Kelemen M , VaidyaD, WatersDDet al. : Hormone therapy and antioxidant vitamins do not improve endothelial vasodilator function in postmenopausal women with established coronary artery disease: a substudy of the Women‘s Angiographic Vitamin and Estrogen (WAVE) trial.Atherosclerosis179, 193–200 (2005).
   PubMed Web of Science ®Google Scholar
• Pilz H , OguoghoA, ChehneF, LupattelliG, PalumboB, SinzingerH: Quitting cigarette smoking results in a fast improvement of in vivo oxidation injury (determined via plasma, serum and urinary isoprostane).Thromb. Res.99, 209–221 (2000).
   PubMed Web of Science ®Google Scholar
• Lykkesfeldt J , PriemeH, LoftS, PoulsenHE: Effect of smoking cessation on plasma ascorbic acid concentration.BMJ313, 91 (1996).
   PubMed Web of Science ®Google Scholar
• Polidori MC , MecocciP, StahlW, SiesH: Cigarette smoking cessation increases plasma levels of several antioxidant micronutrients and improves resistance towards oxidative challenge.Br J. Nutr.90, 147–150 (2003).
   PubMed Web of Science ®Google Scholar
• van den Berkmortel FW , DemackerPN, WollersheimH, ThienT, StalenhoefAF: Smoking or its cessation does not alter the susceptibility to in vitro LDL oxidation.Eur. J. Clin. Invest.30, 972–979 (2000).
   PubMed Web of Science ®Google Scholar
• Wu KK : Platelet activation mechanisms and markers in arterial thrombosis.J. Intern. Med.239, 17–34 (1996).
   PubMed Web of Science ®Google Scholar
• Davi G , PatronoC: Platelet activation and atherothrombosis.N. Engl. J. Med.357, 2482–2494 (2007).
   PubMed Web of Science ®Google Scholar
• Ichiki K , IkedaH, HaramakiN, UenoT, ImaizumiT: Long-term smoking impairs platelet-derived nitric oxide release.Circulation94, 3109–3114 (1996).
   PubMed Web of Science ®Google Scholar
• Takajo Y , IkedaH, HaramakiN, MuroharaT, ImaizumiT: Augmented oxidative stress of platelets in chronic smokers. Mechanisms of impaired platelet-derived nitric oxide bioactivity and augmented platelet aggregability.J. Am. Coll. Cardiol.38, 1320–1327 (2001).
   PubMed Web of Science ®Google Scholar
• Harding SA , SarmaJ, JosephsDHet al. : Upregulation of the CD40/CD40 ligand dyad and platelet-monocyte aggregation in cigarette smokers.Circulation109, 1926–1929 (2004).
   PubMed Web of Science ®Google Scholar
• Meade TW , ImesonJ, StirlingY: Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease.Lancet2(8566), 986–988 (1987).
   PubMed Web of Science ®Google Scholar
• Fitzgerald GA , OatesJA, NowakJ: Cigarette smoking and hemostatic function.Am. Heart J.115, 267–271 (1988).
   PubMed Web of Science ®Google Scholar
• Cimminiello C , ToschiV: Atherothrombosis: the role of platelets.Eur. Heart J.20(Suppl. A), A8–A13 (1999).
   Web of Science ®Google Scholar
• Prentice CRM : Platelets and atherosclerosis.Eur. Heart J.20(Suppl. A), A3–A7 (1999).
   Web of Science ®Google Scholar
• Collaborative overview of randomised trials of antiplatelet therapy – I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients: Antiplatelet Trialists‘ Collaboration. BMJ308, 81–106 (1994).
   PubMed Web of Science ®Google Scholar
• Catella F , HealyD, LawsonJA, FitzgeraldGA: 11-dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation.Proc. Natl Acad. Sci. USA83, 5861–5865 (1986).
   PubMed Web of Science ®Google Scholar
• Eikelboom JW , HirshJ, WeitzJI, JohnstonM, YiQ, YusufS: Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events.Circulation105, 1650–1655 (2002).
   PubMed Web of Science ®Google Scholar
• Fusegawa Y , GotoS, HandaS, KawadaT, AndoY: Platelet spontaneous aggregation in platelet-rich plasma is increased in habitual smokers.Thromb. Res.93, 271–278 (1999).
   PubMed Web of Science ®Google Scholar
• Rubenstein D , JestyJ, BluesteinD: Differences between mainstream and sidestream cigarette smoke extracts and nicotine in the activation of platelets under static and flow conditions.Circulation109, 78–83 (2004).
   PubMed Web of Science ®Google Scholar
• Uedelhoven WM , RutzelA, MeeseCO, WeberPC: Smoking alters thromboxane metabolism in man.Biochim. Biophys. Acta1081, 197–201 (1991).
   PubMedGoogle Scholar
• Barrow SE , WardPS, SleightholmMA, RitterJM, DolleryCT: Cigarette smoking: profiles of thromboxane- and prostacyclin-derived products in human urine.Biochim. Biophys. Acta993, 121–127 (1989).
   PubMed Web of Science ®Google Scholar
• Hung J , KishimotoY, SugioKet al. : Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma.JAMA273, 558–563 (1995).
   PubMed Web of Science ®Google Scholar
• Weber AA , LiesenerS, SchanzA, HohlfeldT, SchrorK: Habitual smoking causes an abnormality in platelet thromboxane A2 metabolism and results in an altered susceptibility to aspirin effects.Platelets11, 177–182 (2000).
   PubMed Web of Science ®Google Scholar
• Hioki H , AokiN, KawanoKet al. : Acute effects of cigarette smoking on platelet-dependent thrombin generation.Eur. Heart J.22, 56–61 (2001).
   PubMed Web of Science ®Google Scholar
• Blann AD , LanzaF, GalajdaPet al. : Increased platelet glycoprotein V levels in patients with coronary and peripheral atherosclerosis – the influence of aspirin and cigarette smoking.Thromb. Haemost.86, 777–783 (2001).
   PubMed Web of Science ®Google Scholar
• Miller GJ , BauerKA, CooperJA, RosenbergRD: Activation of the coagulant pathway in cigarette smokers.Thromb. Haemost.79, 549–553 (1998).
   PubMed Web of Science ®Google Scholar
• Ernst E , ReschKL: Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature.Ann. Intern. Med.118, 956–963 (1993).
   PubMed Web of Science ®Google Scholar
• Woodward M , LoweGD, RumleyA, Tunstall-PedoeH: Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women. The Scottish Heart Health Study.Eur. Heart J.19, 55–62 (1998).
   PubMed Web of Science ®Google Scholar
• Fisher SD , ZarebaW, MossAJet al. : Effect of smoking on lipid and thrombogenic factors two months after acute myocardial infarction.Am. J. Cardiol.86, 813–818 (2000).
   PubMedGoogle Scholar
• Eliasson M , AsplundK, EvrinPE, LundbladD: Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, finrinolytic variables and serum insulin – The Northern Sweden MONICA study.Atherosclerosis113, 41–53 (1995).
   PubMed Web of Science ®Google Scholar
• Tuut M , HenseHW: Smoking, other risk factors and fibrinogen levels. Evidence of effect modification.Ann. Epidemiol.11, 232–238 (2001).
   PubMed Web of Science ®Google Scholar
• Mennen LI , BalkauB, CharlesMA, D‘HourA, le Mauff JM: Gender differences in the relation between fibrinogen, tissue-type plasminogen activator antigen and markers of insulin resistance: effects of smoking. D.E.S.I.R. Study Group. Data from an Epidemiological Study on Insulin Resistance Syndrome. Thromb. Haemost.82, 1106–1111 (1999).
   PubMed Web of Science ®Google Scholar
• Frohlich M , SundM, LowelH, ImhofA, HoffmeisterA, KoenigW: Independent association of various smoking characteristics with markers of systemic inflammation in men. Results from a representative sample of the general population (MONICA Augsburg Survey 1994/95).Eur. Heart J.24, 1365–1372 (2003).
   PubMed Web of Science ®Google Scholar
• Eliasson B , HjalmarsonA, KruseE, LandfeldtB, WestinA: Effect of smoking reduction and cessation on cardiovascular risk factors.Nicotine Tob. Res.3, 249–255 (2001).
   PubMedGoogle Scholar
• Whincup PH , DaneshJ, WalkerMet al. : von Willebrand factor and coronary heart disease: prospective study and meta-analysis.Eur. Heart J.23, 1728–1730 (2002).
   PubMed Web of Science ®Google Scholar
• Blann AD , McCollumCN: Adverse influence of cigarette smoking on the endothelium.Thromb. Haemost.70, 707–711 (1993).
   PubMed Web of Science ®Google Scholar
• Chia S , NewbyDE: Atherosclerosis, cigarette smoking, and endogenous fibrinolysis: is there a direct link?Curr. Atheroscler. Rep.4, 143–148 (2002).
   PubMedGoogle Scholar
• Newby DE , McLeodAL, UrenNGet al. : Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette smoking: direct link between endothelial dysfunction and atherothrombosis.Circulation103, 1936–1941 (2001).
   PubMed Web of Science ®Google Scholar
• Barua RS , AmbroseJA, SahaDC, Eales-ReynoldsLJ: Smoking is associated with altered endothelial-derived fibrinolytic and antithrombotic factors: an in vitro demonstration.Circulation106, 905–908 (2002).
   PubMed Web of Science ®Google Scholar
• Mitchell CT , KamineniA, PalmasW, CushmanM: Tissue factor pathway inhibitor, vascular risk factors and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis.Atherosclerosis doi: 10.1016/j.atherosclerosis.2009.04.024 (2009) (Epub ahead of print).
   PubMedGoogle Scholar
• Hunter KA , GarlickPJ, BroomI, AndersonSE, McNurlanMA: Effects of smoking and abstention from smoking on fibrinogen synthesis in humans.Clin. Sci. (Lond.)100, 459–465 (2001).
   PubMed Web of Science ®Google Scholar
• Wilhelmsen L : Effects of cessation of smoking after myocardial infarction.J. Cardiovasc. Risk5, 173–176 (1998).
   PubMedGoogle Scholar
• McElduff P , DobsonA, BeagleholeR, JacksonR: Rapid reduction in coronary risk for those who quit cigarette smoking.Aust. NZ J. Public Health22, 787–791 (1998).
   PubMed Web of Science ®Google Scholar
• Nilsson P , LundgrenH, SoderstromM, FagerstromKO, Nilsson-EhleP: Effects of smoking cessation on insulin and cardiovascular risk factors – a controlled study of 4 months‘ duration.J. Intern. Med.240, 189–194 (1996).
   PubMed Web of Science ®Google Scholar
• Wennmalm A , BenthinG, GranstromEF, PerssonL, WinellS: Maintained hyperexcretion of thromboxane A2 metabolite in healthy young cigarette smokers: results from a prospective study in randomly sampled males with stable smoking habits.Clin. Physiol.13, 257–264 (1993).
   PubMedGoogle Scholar
• Bain BJ , RothwellM, FeherMD, RobinsonR, BrownJ, SeverPS: Acute changes in haematological parameters on cessation of smoking.JR Soc. Med.85, 80–82 (1992).
   PubMed Web of Science ®Google Scholar
• Dobson AJ , AlexanderHM, HellerRF, LloydDM: How soon after quitting smoking does risk of heart attack decline?J. Clin. Epidemiol.44, 1247–1253 (1991).
   PubMed Web of Science ®Google Scholar
• Reaven GM , ChenYD: Insulin resistance, its consequences, and coronary heart disease. Must we choose one culprit?Circulation93, 1780–1783 (1996).
   PubMed Web of Science ®Google Scholar
• Kendall DM , SobelBE, CoulstonAMet al. : The insulin resistance syndrome and coronary artery disease.Coron. Artery Dis.14, 335–348 (2003).
   PubMed Web of Science ®Google Scholar
• Wannamethee SG , LoweGD, ShaperAG, RumleyA, LennonL, WhincupPH: Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in Type 2 diabetic men with and without coronary heart disease.Diabetologia47, 1557–1565 (2004).
   PubMed Web of Science ®Google Scholar
• Theuma P , FonsecaVA: Inflammation, insulin resistance, and atherosclerosis.Metabol. Synd. Relat. Dis.2, 105–113 (2004).
   PubMed Web of Science ®Google Scholar
• Egan BM , GreeneEL, GoodfriendTL: Insulin resistance and cardiovascular disease.Am J. Hypertens.14, 116S–125S (2001).
   PubMed Web of Science ®Google Scholar
• Reaven G , TsaoPS: Insulin resistance and compensatory hyperinsulinemia: the key player between cigarette smoking and cardiovascular disease?J. Am. Coll. Cardiol.41, 1044–1047 (2003).
   PubMed Web of Science ®Google Scholar
• Qiao Q , ValleT, NissinenA, TuomilehtoJ: Smoking and the risk of diabetes in elderly Finnish men. Retrospective analysis of data from a 30-year follow-up study.Diabetes Care22, 1821–1826 (1999).
   PubMed Web of Science ®Google Scholar
• Eliasson B : Cigarette smoking and diabetes.Prog. Cardiovasc. Dis.45, 405–413 (2003).
   PubMed Web of Science ®Google Scholar
• Rimm RB , ChanJ, StampferMJ, ColditzGA, WillettWC: Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men.BMJ310, 555–559 (1995).
   PubMed Web of Science ®Google Scholar
• Will JC , GaluskaDA, FordES, MokdadA, CalleEE: Cigarette smoking and diabetes mellitus: evidence of a positive association from a large prospective cohort study.Int. J. Epidemiol.30, 540–546 (2001).
   PubMed Web of Science ®Google Scholar
• Östgren C , LindbladU, RanstamJ, MelanderA, RastamL: Associations between smoking and +β-cell function in a non-hypertensive and non-diabetic population – Skaraborg Hypertension and Diabetes project.Diabet. Med.17, 445–450 (2000).
   PubMed Web of Science ®Google Scholar
• Haire-Joshu D , GlasgowRE, TibbsTL: Smoking and diabetes.Diabetes Care22, 1887–1898 (1999).
   PubMed Web of Science ®Google Scholar
• Baggio B , BudakovicA, DallaVM, SallerA, BruseghinM, FiorettoP: Effects of cigarette smoking on glomerular structure and function in Type 2 diabetic patients.J. Am. Soc. Nephrol.13, 2730–2736 (2002).
   PubMed Web of Science ®Google Scholar
• Poulsen PL , EbbehojE, HansenKW, MogensenCE: Effects of smoking on 24-h ambulatory blood pressure and autonomic function in normoalbuminuric insulin-dependent diabetes mellitus patients.Am J. Hypertens.11, 1093–1099 (1998).
   PubMed Web of Science ®Google Scholar
• Sargeant LA , KhawKT, BinghamSet al. : Cigarette smoking and glycaemia: the EPIC-Norfolk study.Int. J. Epidemiol.30, 547–554 (2001).
   PubMed Web of Science ®Google Scholar
• Wannamethee SG , ShaperAG, PerryIJ: Smoking as a modifiable risk factor for Type 2 diabetes in middle-aged men.Diabetes Care24, 1590–1595 (2001).
   PubMed Web of Science ®Google Scholar
• Kinosian B , GlickH, GarlandG: Cholesterol and coronary heart disease: predicting risks by levels and ratios.Ann. Intern. Med.121, 641–647 (1994).
   PubMed Web of Science ®Google Scholar
• Castelli WP : Lipids, risk factors and ischaemic heart disease.Atherosclerosis124, S1–S9 (1996).
   PubMed Web of Science ®Google Scholar
• Karvonen M , OrmaE, KeysA, FidanzaF, BrozekJ: Cigarette smoking, serum-cholesterol, blood-pressure, and body fatness; observations in Finland.Lancet1, 492–494 (1959).
   PubMed Web of Science ®Google Scholar
• Sanderson KJ , van Rij AM, Wade CR, Sutherland WH: Lipid peroxidation of circulating low density lipoproteins with age, smoking and in peripheral vascular disease. Atherosclerosis118, 45–51 (1995).
   PubMed Web of Science ®Google Scholar
• Craig WY , PalomakiGE, HaddowJE: Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data.BMJ298(6676), 784–788 (1989).
   PubMedGoogle Scholar
• Freeman DJ , CaslakeMJ, GriffinBAet al. : The effect of smoking on post-heparin lipoprotein and hepatic lipase, cholesteryl ester transfer protein and lecithin:cholesterol acyl transferase activities in human plasma.Eur. J. Clin. Invest.28, 584–591 (1998).
   PubMed Web of Science ®Google Scholar
• Jarvik GP , TsaiNT, McKinstryLAet al. : Vitamin C and E intake is associated with increased paraoxonase activity.Arterioscler. Thromb. Vasc. Biol.22, 1329–1333 (2002).
   PubMed Web of Science ®Google Scholar
• James RW , LevievI, RighettiA: Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease.Circulation101, 2252–2257 (2000).
   PubMed Web of Science ®Google Scholar
• Gerace TA , HollisJ, OckeneJK, SvendsenK: Smoking cessation and change in diastolic blood pressure, body weight, and plasma lipids. MRFIT Research Group.Prev. Med.20, 602–620 (1991).
   PubMed Web of Science ®Google Scholar
• Ludviksdottir D , BlondalT, FranzonM, GudmundssonTV, SaweU: Effects of nicotine nasal spray on atherogenic and thrombogenic factors during smoking cessation.J. Intern. Med.246, 61–66 (1999).
   PubMed Web of Science ®Google Scholar
• Green MS , HarariG: A prospective study of the effects of changes in smoking habits on blood count, serum lipids and lipoproteins, body weight and blood pressure in occupationally active men. The Israeli CORDIS Study.J. Clin. Epidemiol.48, 1159–1166 (1995).
   PubMed Web of Science ®Google Scholar
• Maeda K , NoguchiY, FukuiT: The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: a meta-analysis.Prev. Med.37, 283–290 (2003).
   PubMed Web of Science ®Google Scholar
• Nygard O , VollsetSE, RefsumHet al. : Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study.JAMA274, 1526–1533 (1995).
   PubMed Web of Science ®Google Scholar
• O‘Callaghan P , MeleadyR, FitzgeraldT, GrahamI: Smoking and plasma homocysteine.Eur. Heart J.23, 1580–1586 (2002).
   PubMed Web of Science ®Google Scholar
• Wilcken DE : Homocysteine, smoking and vascular disease.Eur. Heart J.23, 1559–1560 (2002).
   PubMed Web of Science ®Google Scholar
• Yamamoto M , HaraH, AdachiT: Effects of homocysteine on the binding of extracellular-superoxide dismutase to the endothelial cell surface.FEBS Lett.486, 159–162 (2000).
   PubMed Web of Science ®Google Scholar
• Verhaar MC , StroesE, RabelinkTJ: Folates and cardiovascular disease.Arterioscler. Thromb. Vasc. Biol.22, 6–13 (2002).
   PubMed Web of Science ®Google Scholar
• Kennedy BP , FaragNH, ZieglerMG, MillsPJ: Relationship of systolic blood pressure with plasma homocysteine: importance of smoking status.J. Hypertens.12, 1307–1312 (2003).
   Google Scholar
• Targher G , MuggeoM, BertoliniLet al. : Cigarette smoking and plasma total homocysteine levels in young adults with Type 1 diabetes.Diab. Care23, 524–528 (2000).
   PubMed Web of Science ®Google Scholar
• Wald NJ , WattHC, LawMR, WeirDG, McPartlinJ, ScottJM: Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention.Arch. Intern. Med.158, 862–867 (1998).
   PubMed Web of Science ®Google Scholar
• Nygard O , NordrehaugJE, RefsumH, UelandPM, FarstadM, VollsetSE: Plasma homocysteine levels and mortality in patients with coronary artery disease.N. Engl. J. Med.337, 230–236 (1997).
   PubMed Web of Science ®Google Scholar
• Hackam DG , AnandSS: Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence.J. Am. Med. Assoc.290, 932–940 (2003).
   PubMed Web of Science ®Google Scholar
• Nygard O , RefsumH, UelandPM, VollsetSE: Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study.Am. J. Clin. Nutr.67, 263–270 (1998).
   PubMed Web of Science ®Google Scholar
• Bergmark C , MansoorMA, SvardalA, de Faire U: Redox status of plasma homocysteine and related aminothiols in smoking and nonsmoking young adults. Clin. Chem. Lab. Med.43, 1997–1999 (1997).
   Google Scholar
• Blom HJ : Determinants of plasma homocysteine.Am. J. Clin. Nutr.67, 188–189 (1998).
   PubMed Web of Science ®Google Scholar
• Stein JH , BusharaM, BusharaK, McBridePE, JorenbyDE, FioreMC: Smoking cessation, but not smoking reduction, reduces plasma homocysteine levels.Clin. Cardiol.25, 23–26 (2002).
   PubMed Web of Science ®Google Scholar
• Tonstad S , UrdalP: Does short-term smoking cessation reduce plasma total homocysteine concentrations?Scand. J. Clin. Lab. Invest.62, 279–284 (2002).
   PubMed Web of Science ®Google Scholar
• Brattstrom L , WilckenDE: Homocysteine and cardiovascular disease: cause or effect?Am. J. Clin. Nutr.72, 315–323 (2000).
   PubMed Web of Science ®Google Scholar
• Havranek EP : Primary prevention of CHD: nine ways to reduce risk.Am. Fam. Physician59, 1455–1463 (1999).
   PubMed Web of Science ®Google Scholar
• Benowitz NL , JacobP, III: Effects of cigarette smoking and carbon monoxide on nicotine and cotinine metabolism. Clin. Pharmacol. Ther.67, 653–659 (2000).
   PubMed Web of Science ®Google Scholar
• Wilcken DE , WilckenB: The natural history of vascular disease in homocystinuria and the effects of treatment.J. Inherit. Metab. Dis.20, 295–300 (1997).
   PubMed Web of Science ®Google Scholar
• Yap S , NaughtenER, WilckenB, WilckenDE, BoersGH: Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine β-synthase deficiency: effects of homocysteine-lowering therapy.Semin. Thromb. Hemost.26, 335–340 (2000).
   PubMed Web of Science ®Google Scholar
• Yap S , BoersGH, WilckenBet al. : Vascular outcome in patients with homocystinuria due to cystathionine β-synthase deficiency treated chronically: a multicenter observational study.Arterioscler. Thromb. Vasc. Biol.21, 2080–2085 (2001).
   PubMed Web of Science ®Google Scholar
• B-Vitamin Treatment Trialists‘ Collaboration: Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials. Am. Heart J.151, 282–287 (2006).
   PubMed Web of Science ®Google Scholar
• Homocysteine Lowering Trialists‘ Collaboration: Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am. J. Clin. Nutr.82, 806–812 (2005).
   PubMed Web of Science ®Google Scholar
• Liebson PR : Women‘s Health Initiative (WHI) Dietary Trial and Norwegian Vitamin Trial (NORVIT).Prev. Cardiol.9, 178–182 (2006).
   PubMedGoogle Scholar
• Bonaa KH , NjolstadI, UelandPMet al. : Homocysteine lowering and cardiovascular events after acute myocardial infarction.N. Engl. J. Med.354, 1578–1588 (2006).
   PubMed Web of Science ®Google Scholar
• Zhang F , ChenY, HeimanM, DimarchiR: Leptin: structure, function and biology.Vitam. Horm.71, 345–372 (2005).
   PubMed Web of Science ®Google Scholar
• Friedman JM , HalaasJL: Leptin and the regulation of body weight in mammals.Nature395, 763–770 (1998).
   PubMed Web of Science ®Google Scholar
• Beltowski J : Leptin and atherosclerosis.Atherosclerosis189, 47–60 (2006).
   PubMed Web of Science ®Google Scholar
• Wei M , SternMP, HaffnerSM: Serum leptin levels in Mexican Americans and non-Hispanic Whites: association with body mass index and cigarette smoking.Ann. Epidemiol.7, 81–86 (1997).
   PubMed Web of Science ®Google Scholar
• Hodge AM , WestermanRA, de Courten MP, Collier GR, Zimmet PZ, Alberti KG: Is leptin sensitivity the link between smoking cessation and weight gain? Int. J. Obes. Relat. Metab. Disord.21, 50–53 (1997).
   PubMed Web of Science ®Google Scholar
• Mantzoros CS , LioliosAD, TritosNAet al. : Circulating insulin concentrations, smoking, and alcohol intake are important independent predictors of leptin in young healthy men.Obes. Res.6, 179–186 (1998).
   PubMedGoogle Scholar
• Donahue RP , ZimmetP, BeanJAet al. : Cigarette smoking, alcohol use, and physical activity in relation to serum leptin levels in a multiethnic population: The Miami Community Health Study.Ann. Epidemiol.9, 108–113 (1999).
   PubMed Web of Science ®Google Scholar
• Targher G , ZenariL, FacciniG, FalezzaG, MuggeoM, ZoppiniG: Serum leptin concentrations in young smokers with Type 1 diabetes.Diabetes Care24, 793 (2001).
   PubMed Web of Science ®Google Scholar
• Tanaka M , UmezakiM, NatsuharaKet al. : No difference in serum leptin concentrations between urban-dwelling Austronesians and Non-Austronesians in Papua New Guinea.Am. J. Hum. Biol.17, 696–703 (2005).
   PubMed Web of Science ®Google Scholar
• Reseland JE , MundalHH, HollungKet al. : Cigarette smoking may reduce plasma leptin concentration via catecholamines.Prostaglandins Leukot. Essent. Fatty Acids73, 43–49 (2005).
   PubMed Web of Science ®Google Scholar
• Perkins KA , BrogeM, GerlachDet al. : Acute nicotine reinforcement, but not chronic tolerance, predicts withdrawal and relapse after quitting smoking.Health Psychol.21, 332–339 (2002).
   PubMed Web of Science ®Google Scholar
• Eliasson B , SmithU: Leptin levels in smokers and long-term users of nicotine gum.Eur. J. Clin. Invest.29, 145–152 (1999).
   PubMed Web of Science ®Google Scholar
• Yoshinari M , WakisakaM, FujishimaM: Serum leptin levels in smokers with Type 2 diabetes.Diabetes Care21, 516–517 (1998).
   PubMed Web of Science ®Google Scholar
• Nicklas BJ , TomoyasuN, MuirJ, GoldbergAP: Effects of cigarette smoking and its cessation on body weight and plasma leptin levels.Metabolism48, 804–808 (1999).
   PubMed Web of Science ®Google Scholar
• Nystrom F , EkmanB, OsterlundM, LindstromT, OhmanKP, ArnqvistHJ: Serum leptin concentrations in a normal population and in GH deficiency: negative correlation with testosterone in men and effects of GH treatment.Clin. Endocrinol. (Oxf.)47, 191–198 (1997).
   PubMed Web of Science ®Google Scholar
• Elbatarny HS , MauriceDH: Leptin-mediated activation of human platelets: involvement of a leptin receptor and phosphodiesterase 3A-containing cellular signaling complex.Am. J. Physiol. Endocrinol. Metab.289, E695–E702 (2005).
   PubMed Web of Science ®Google Scholar
• Wolk R , BergerP, LennonRJ, BrilakisES, JohnsonBD, SomersVK: Plasma leptin and prognosis in patients with established coronary atherosclerosis.J. Am. Coll. Cardiol.44, 1819–1824 (2004).
   PubMed Web of Science ®Google Scholar
• Soderberg S , AhrenB, StegmayrBet al. : Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort.Stroke30, 328–337 (1999).
   PubMed Web of Science ®Google Scholar
• Soderberg S , AhrenB, JanssonJHet al. : Leptin is associated with increased risk of myocardial infarction.J. Intern. Med.246, 409–418 (1999).
   PubMed Web of Science ®Google Scholar
• Leyva F , AnkerSD, EgererK, StevensonJC, KoxWJ, CoatsAJ: Hyperleptinaemia in chronic heart failure. Relationships with insulin.Eur. Heart J.19, 1547–1551 (1998).
   PubMed Web of Science ®Google Scholar
• Reilly MP , IqbalN, SchuttaMet al. : Plasma leptin levels are associated with coronary atherosclerosis in Type 2 diabetes.J. Clin. Endocrinol. Metab.89, 3872–3878 (2004).
   PubMed Web of Science ®Google Scholar
• Iribarren C , HussonG, GoASet al. : Plasma leptin levels and coronary artery calcification in older adults.J. Clin. Endocrinol. Metab.92, 729–732 (2007).
   PubMed Web of Science ®Google Scholar
• Luo JD , ZhangGS, ChenMS: Leptin and cardiovascular diseases.Timely Top. Med. Cardiovasc. Dis.9, E34 (2005).
   PubMedGoogle Scholar
• Beltowski J , Jamroz-WisniewskaA, WidomskaS: Adiponectin and its role in cardiovascular diseases.Cardiovasc. Hematol. Disord. Drug Targets8, 7–46 (2008).
   PubMedGoogle Scholar
• Abbasi F , FarinHM, LamendolaCet al. : The relationship between plasma adiponectin concentration and insulin resistance is altered in smokers.J. Clin. Endocrinol. Metab.91, 5002–5007 (2006).
   PubMed Web of Science ®Google Scholar
• Al-Daghri NM , Al-AttasOS, HussainT, SabicoS, BamakhramahA: Altered levels of adipocytokines in Type 2 diabetic cigarette smokers.Diabetes Res. Clin. Pract.83, E37–E39 (2009).
   PubMedGoogle Scholar
• Otsuka F , KojimaS, MaruyoshiHet al. : Smoking cessation is associated with increased plasma adiponectin levels in men.J. Cardiol.53, 219–225 (2009).
   PubMed Web of Science ®Google Scholar
• Efstathiou SP , SkevaII, DimasCet al. : Smoking cessation increases serum adiponectin levels in an apparently healthy Greek population.Atherosclerosis205(2), 632–636 (2009).
   PubMed Web of Science ®Google Scholar
• Koerner A , KratzschJ, KiessW: Adipocytokines: leptin – the classical, resistin – the controversical, adiponectin – the promising, and more to come.Best Pract. Res. Clin. Endocrinol. Metab.19, 525–546 (2005).
   PubMed Web of Science ®Google Scholar
• Frankel DS , VasanRS, D‘AgostinoRB Sr et al.: Resistin, adiponectin, and risk of heart failure the Framingham offspring study. J. Am. Coll. Cardiol.53, 754–762 (2009).
   PubMed Web of Science ®Google Scholar
• Chen BH , SongY, DingELet al. : Circulating levels of resistin and risk of Type 2 diabetes in men and women: results from two prospective cohorts.Diabetes Care32, 329–334 (2009).
   PubMed Web of Science ®Google Scholar
• Pilz S , WeihrauchG, SeelhorstUet al. : Implications of resistin plasma levels in subjects undergoing coronary angiography.Clin. Endocrinol. (Oxf.)66, 380–386 (2007).
   PubMed Web of Science ®Google Scholar
• Shin HJ , ParkS, YoonSJet al. : Association between serum resistin and carotid intima media thickness in hypertension patients.Int. J. Cardiol.125, 79–84 (2008).
   PubMed Web of Science ®Google Scholar
• Ahn KS , AggarwalBB: Transcription factor NF-κB: a sensor for smoke and stress signals.Ann. NY Acad. Sci.1056, 218–233 (2005).
   PubMed Web of Science ®Google Scholar
• Weber C , ErlW: Modulation of vascular cell activation, function, and apoptosis: role of antioxidants and nuclear factor-κ B.Curr. Top. Cell. Regul.36, 217–235 (2000).
   PubMedGoogle Scholar
• Hajra L , EvansAI, ChenM, HydukSJ, CollinsT, CybulskyMI: The NF-κ B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation.Proc. Natl Acad. Sci. USA97, 9052–9057 (2000).
   PubMed Web of Science ®Google Scholar
• Shen Y , RattanV, SultanaC, KalraVK: Cigarette smoke condensate-induced adhesion molecule expression and transendothelial migration of monocytes.Am. J. Physiol.270, H1624 (1996).
   PubMedGoogle Scholar
• Ueno H , PradhanS, SchlesselD, HirasawaH, SumpioBE: Nicotine enhances human vascular endothelial cell expression of ICAM-1 and VCAM-1 via protein kinase C, p38 mitogen-activated protein kinase, NF-κB, and AP-1.Cardiovasc. Toxicol.6, 39–50 (2006).
   PubMed Web of Science ®Google Scholar
• Cirillo P , DE Rosa S, Pacileo M et al.: Nicotine induces tissue factor expression in cultured endothelial and smooth muscle cells. J. Thromb. Haemost.4, 453–458 (2006).
   PubMed Web of Science ®Google Scholar
• Ryan S , TaylorCT, McNicholasWT: Predictors of elevated nuclear factor-κB-dependent genes in obstructive sleep apnea syndrome.Am. J. Respir. Crit. Care Med.174, 824–830 (2006).
   PubMed Web of Science ®Google Scholar
• Cucina A , CorvinoV, SapienzaPet al. : Nicotine regulates basic fibroblastic growth factor and transforming growth factor β1 production in endothelial cells.Biochem. Biophys. Res. Commun.257, 306–312 (1999).
   PubMed Web of Science ®Google Scholar
• Shevchenko AO , ShevchenkoOP, OrlovaOV, TulikovMV: [Neoangiogenesis and coronary atherosclerosis: diagnostic value of a novel biochemical marker placenta growth factor in patients with ischemic heart disease].Kardiologiia46, 9–15 (2006).
   PubMed Web of Science ®Google Scholar
• Yamamoto Y , KoharaK, TabaraY, MikiT: Association between carotid arterial remodeling and plasma concentration of circulating hepatocyte growth factor.J. Hypertens.19, 1975–1979 (2001).
   PubMed Web of Science ®Google Scholar
• Yamasaki K , AokiM, MakinoHet al. : Effect of nifedipine on endothelial function in normotensive smokers: potential contribution of increase in circulating hepatocyte growth factor.J. Hum. Hypertens.18, 701–705 (2004).
   PubMed Web of Science ®Google Scholar
• Juul A , ScheikeT, DavidsenM, GyllenborgJ, JorgensenT: Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study.Circulation106, 939–944 (2002).
   PubMed Web of Science ®Google Scholar
• Colao A , SpieziaS, DiSCet al. : Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age.J. Endocrinol. Invest.28, 440–448 (2005).
   PubMed Web of Science ®Google Scholar
• Fischer F , SchulteH, MohanSet al. : Associations of insulin-like growth factors, insulin-like growth factor binding proteins and acid-labile subunit with coronary heart disease.Clin. Endocrinol. (Oxf.)61, 595–602 (2004).
   PubMed Web of Science ®Google Scholar
• Gunes T , KokluE, YikilmazAet al. : Influence of maternal smoking on neonatal aortic intima-media thickness, serum IGF-I and IGFBP-3 levels.Eur. J. Pediatr.166, 1039–1044 (2007).
   PubMed Web of Science ®Google Scholar
• Eaton CB , GramlingR, ParkerDR, RobertsMB, LuB, RidkerPM: Prospective association of vascular endothelial growth factor-A (VEGF-A) with coronary heart disease mortality in southeastern New England.Atherosclerosis200, 221–227 (2008).
   PubMed Web of Science ®Google Scholar
• Kimura K , HashiguchiT, DeguchiTet al. : Serum VEGF – as a prognostic factor of atherosclerosis.Atherosclerosis194, 182–188 (2007).
   PubMed Web of Science ®Google Scholar
• Council C : Envirmental Tobacco Smoke – Measuring Exposures and Assessing Health Effects. National Academic Press, Washington DC, USA, 30–31 (1986).
   Google Scholar
• Carty CS , HuribalM, MarsanBU, RicottaJJ, DryjskiM: Nicotine and its metabolite cotinine are mitogenic for human vascular smooth muscle cells.J. Vasc. Surg.25, 682–688 (1997).
   PubMed Web of Science ®Google Scholar
• Cucina A , SapienzaP, CorvinoVet al. : Nicotine-induced smooth muscle cell proliferation is mediated through bFGF and TGF-β 1.Surgery127, 316–322 (2000).
   PubMed Web of Science ®Google Scholar
• Knuutinen A , KokkonenN, RisteliJet al. : Smoking affects collagen synthesis and extracellular matrix turnover in human skin.Br. J. Dermatol.146, 588–594 (2002).
   PubMed Web of Science ®Google Scholar
• Prescott SM , McIntyreTM, ZimmermanGA, StafforiniDM: Sol Sherry lecture in thrombosis: molecular events in acute inflammation.Arterioscler. Thromb. Vasc. Biol.22, 727–733 (2002).
   PubMed Web of Science ®Google Scholar
• Madsen H , DyerbergJ: Cigarette smoking and its effects on the platelet-vessel wall interaction.Scand. J. Clin. Lab. Invest.44, 203–206 (1984).
   PubMed Web of Science ®Google Scholar
• Fusegawa Y , HandaS: Platelet aggregation induced by ADP or epinephrine is enhanced in habitual smokers.Thromb. Res.97, 287–295 (2000).
   PubMed Web of Science ®Google Scholar
• Gidding SS , XieX, LiuK, ManolioT, FlackJM, GardinJM: Cardiac function in smokers and nonsmokers: the CARDIA study. The Coronary Artery Risk Development in Young Adults Study.J. Am. Coll. Cardiol.26, 211–216 (1995).
   PubMed Web of Science ®Google Scholar
• Morgado PB , ChenHC, PatelV, HerbertL, KohnerEM: The acute effect of smoking on retinal blood flow in subjects with and without diabetes.Ophthalmology101, 1220–1226 (1994).
   PubMed Web of Science ®Google Scholar
• Meurrens K , RufS, RossG, SchleefR, von Holt K, Schluter KD: Smoking accelerates the progression of hypertension-induced myocardial hypertrophy to heart failure in spontaneously hypertensive rats. Cardiovasc. Res.76, 311–322 (2007).
   PubMed Web of Science ®Google Scholar
• Muscat JE , HarrisRE, HaleyNJ, WynderEL: Cigarette smoking and plasma cholesterol.Am. Heart J.121, 141–147 (1991).
   PubMed Web of Science ®Google Scholar
• Tell GS , PolakJF, WardBJ, KittnerSJ, SavagePJ, RobbinsJ: Relation of smoking with carotid artery wall thickness and stenosis in older adults. The Cardiovascular Health Study. The Cardiovascular Health Study (CHS) Collaborative Research Group.Circulation90, 2905–2908 (1994).
   PubMed Web of Science ®Google Scholar
• Stefanadis C , VlachopoulosC, TsiamisEet al. : Unfavorable effects of passive smoking on aortic function in men.Ann. Intern. Med.128, 426–434 (1998).
   PubMed Web of Science ®Google Scholar
• Caro CG , LeverMJ, ParkerKH, FishPJ: Effect of cigarette smoking on the pattern of arterial blood flow: possible insight into mechanisms underlying the development of arteriosclerosis.Lancet2, 11–13 (1987).
   PubMed Web of Science ®Google Scholar
• Stefanadis C , DernellisJ, ToutouzasP: Mechanical properties of the aorta determined by the pressure-diameter relation.Pathol. Biol. (Paris)47, 696–704 (1999).
   PubMedGoogle Scholar
• Liang YL , ShielLM, TeedeHet al. : Effects of blood pressure, smoking, and their interaction on carotid artery structure and function.Hypertension37, 6–11 (2001).
   PubMed Web of Science ®Google Scholar
• Auerbach O , HammondEC, GarfinkelL: Smoking in relation to atherosclerosis of the coronary arteries.N. Engl. J. Med.273, 775–779 (1965).
   PubMed Web of Science ®Google Scholar
• Kornowski R : Impact of smoking on coronary atherosclerosis and remodeling as determined by intravascular ultrasonic imaging.Am. J. Cardiol.83, 443–435, A9 (1999).
   PubMed Web of Science ®Google Scholar
• Curfs DM , KnaapenAM, PachenDMet al. : Polycyclic aromatic hydrocarbons induce an inflammatory atherosclerotic plaque phenotype irrespective of their DNA binding properties.FASEB J.19, 1290–1292 (2005).
   PubMed Web of Science ®Google Scholar
• Nakanishi K , ZhaoZQ, Vinten-JohansenJ, HudspethDA, McGeeDS, HammonJW Jr: Blood cardioplegia enhanced with nitric oxide donor SPM-5185 counteracts postischemic endothelial and ventricular dysfunction. J. Thorac. Cardiovasc. Surg.109, 1146–1154 (1995).
   PubMed Web of Science ®Google Scholar
• Uchimoto S , TsumuraK, HayashiTet al. : Impact of cigarette smoking on the incidence of Type 2 diabetes mellitus in middle-aged Japanese men: the Osaka Health Survey.Diabet. Med.16, 951–955 (1999).
   PubMedGoogle Scholar
• Persson PG , CarlssonS, SvanstromL, OstensonCG, EfendicS, GrillV: Cigarette smoking, oral moist snuff use and glucose intolerance.J. Intern. Med.248, 103–110 (2000).
   PubMed Web of Science ®Google Scholar
• Patja K , JousilahtiP, HuG, ValleT, QiaoQ, TuomilehtoJ: Effects of smoking, obesity and physical activity on the risk of Type 2 diabetes in middle-aged Finnish men and women.J. Intern. Med.258, 356–362 (2005).
   PubMed Web of Science ®Google Scholar
• Wang XL , WangJ, WilckenDE: Interactive effect of the p53 gene and cigarette smoking on coronary artery disease.Cardiovasc. Res.35, 250–255 (1997).
   PubMed Web of Science ®Google Scholar
• Ardissino D , MannucciPM, MerliniPAet al. : Prothrombotic genetic risk factors in young survivors of myocardial infarction.Blood94, 46–51 (1999).
   PubMed Web of Science ®Google Scholar
• Li YH , ChenJH, TsaiWCet al. : Synergistic effect of thrombomodulin promoter -33G/A polymorphism and smoking on the onset of acute myocardial infarction.Thromb. Haemost.87, 86–91 (2002).
   PubMed Web of Science ®Google Scholar

▪ Website

• NIH: Definitions Working Group (2000). www.fda.gov/ohrms/dockets/ac/00/slides/3593S1_03_downing.ppt
   Google Scholar